Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with p
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
PALM OIL | TOPICAL | SOAP | 8002753 | 5QUO05548Z | NA | ||
PALMITIC ACID | INTRAVENOUS | INJECTION, SUSPENSION | 57103 | 2V16EO95H1 | NA | ||
PALMITIC ACID | ORAL | TABLET | 57103 | 2V16EO95H1 | 6mg | ||
PALMITOSTEARIC ACID | ORAL | TABLET | 61790383 | Q8Y7S3B85M | 240mg | ||
PARABENS | ORAL | CAPSULE | NA | 0.16mg | |||
PARABENS | ORAL | CAPSULE, EXTENDED RELEASE | NA | NA | |||
PARABENS | ORAL | DROPS | NA | NA | |||
PARABENS | ORAL | POWDER, FOR SUSPENSION | NA | NA | |||
PARABENS | ORAL | SOLUTION | NA | NA | |||
PARABENS | ORAL | SUSPENSION | NA | NA | |||
PARABENS | ORAL | TABLET | NA | NA | |||
PARABENS | ORAL | TABLET, EXTENDED RELEASE | NA | NA | |||
PARAFFIN | ORAL | CAPSULE | 8002742 | I9O0E3H2ZE | 68mg | ||
PARAFFIN | ORAL | CAPSULE, EXTENDED RELEASE | 8002742 | I9O0E3H2ZE | 50mg | ||
PARAFFIN | ORAL | TABLET | 8002742 | I9O0E3H2ZE | 0.7mg | ||
PARAFFIN | ORAL | TABLET, COATED | 8002742 | I9O0E3H2ZE | 0.07mg | ||
PARAFFIN | ORAL | TABLET, DELAYED RELEASE | 8002742 | I9O0E3H2ZE | 0.2mg | ||
PARAFFIN | ORAL | TABLET, EXTENDED RELEASE | 8002742 | I9O0E3H2ZE | 321mg | ||
PARAFFIN | RECTAL | OINTMENT | 8002742 | I9O0E3H2ZE | 5%w/w | ||
PARAFFIN | TOPICAL | AEROSOL, FOAM | 8002742 | I9O0E3H2ZE | 94.93%w/w | ||
PARAFFIN | TOPICAL | CREAM | 8002742 | I9O0E3H2ZE | 300mg | ||
PARAFFIN | TOPICAL | OINTMENT | 8002742 | I9O0E3H2ZE | 1800mg | ||
PARAFFIN | TOPICAL | SOAP | 8002742 | I9O0E3H2ZE | 0.4%w/w | ||
PARFUM CREME 45/3 | TOPICAL | GEL | NA | 0.1%w/w | |||
PEANUT OIL | AURICULAR (OTIC) | OIL | 8002037 | 5TL50QU0W4 | 498mg | ||
PEANUT OIL | INTRAMUSCULAR | INJECTION | 8002037 | 5TL50QU0W4 | NA | ||
PEANUT OIL | OPHTHALMIC | SOLUTION | 8002037 | 5TL50QU0W4 | NA | ||
PEANUT OIL | ORAL | CAPSULE | 8002037 | 5TL50QU0W4 | 313.8mg | ||
PEANUT OIL | ORAL | TABLET | 8002037 | 5TL50QU0W4 | NA | ||
PEANUT OIL | TOPICAL | CREAM | 8002037 | 5TL50QU0W4 | 3%w/w | ||
PEANUT OIL | TOPICAL | CREAM, AUGMENTED | 8002037 | 5TL50QU0W4 | 10%w/w | ||
PEANUT OIL | TOPICAL | OIL | 8002037 | 5TL50QU0W4 | 3000mg | ||
PEANUT OIL | VAGINAL | CREAM | 8002037 | 5TL50QU0W4 | 9%w/w | ||
PECTIN | DENTAL | PASTE | 9000695 | 89NA02M4RX | 110mg | ||
PECTIN | NASAL | SPRAY | 9000695 | 89NA02M4RX | 10mg | ||
PECTIN | ORAL | CAPSULE, EXTENDED RELEASE | 9000695 | 89NA02M4RX | 5.45mg | ||
PECTIN | ORAL | POWDER, FOR SUSPENSION | 9000695 | 89NA02M4RX | 1530mg | ||
PECTIN | ORAL | TABLET | 9000695 | 89NA02M4RX | 1mg | ||
PECTIN, CITRUS | DENTAL | PASTE | 9000695 | 47EQO8LE7H | 16.6%w/w | ||
PECTIN, CITRUS | ORAL | POWDER, FOR SUSPENSION | 9000695 | 47EQO8LE7H | 765mg | ||
PECTIN, CITRUS | ORAL | TABLET | 9000695 | 47EQO8LE7H | 0.35mg | ||
PEG 6-32 STEARATE/GLYCOL STEARATE | TOPICAL | CREAM | NA | 19.6%w/w | |||
PEG 6-32 STEARATE/GLYCOL STEARATE | VAGINAL | CREAM | NA | 19.6%w/w | |||
PEG/PPG-18/18 DIMETHICONE | TOPICAL | GEL | 68937553 | 9H0AO7T794 | 1%w/w | ||
PEG/PPG-18/18 DIMETHICONE | TRANSDERMAL | FILM, EXTENDED RELEASE | 68937553 | 9H0AO7T794 | NA | ||
PEG/PPG-4/30 COPOLYMER | OPHTHALMIC | SOLUTION | 6SG11EPD3Z | NA | |||
PEG-100 MONOSTEARATE | TOPICAL | CREAM | 9004993 | YD01N1999R | 552mg | ||
PEG-100 MONOSTEARATE | TOPICAL | CREAM, AUGMENTED | 9004993 | YD01N1999R | 0.5%w/w | ||
PEG-100 MONOSTEARATE | TOPICAL | LOTION | 9004993 | YD01N1999R | 1%w/w | ||
PEG-100 MONOSTEARATE | VAGINAL | CREAM | 9004993 | YD01N1999R | 100mg | Y | |
PEG-120 GLYCERYL STEARATE | TOPICAL | CREAM | 9011216 | 6941286E4I | 5%w/w | ||
PEG-120 GLYCERYL STEARATE | VAGINAL | CREAM | 9011216 | 6941286E4I | 2%w/w | ||
PEG-120 METHYL GLUCOSE DIOLEATE | TOPICAL | SHAMPOO | 86893198 | YM0K64F20V | 1.8%w/w | ||
PEG-20 METHYL GLUCOSE SESQUISTEARATE | TOPICAL | CREAM | 72175394 | 0345752X7U | 3.5%w/w | ||
PEG-20 METHYL GLUCOSE SESQUISTEARATE | TOPICAL | CREAM, AUGMENTED | 72175394 | 0345752X7U | 70mg | ||
PEG-20 METHYL GLUCOSE SESQUISTEARATE | TOPICAL | LOTION | 72175394 | 0345752X7U | 3%w/w | ||
PEG-20 SORBITAN ISOSTEARATE | TOPICAL | CREAM | 66794589 | X958PZJ9ON | 6%w/w | ||
PEG-25 PROPYLENE GLYCOL STEARATE | TOPICAL | CREAM | X21KPH4633 | 2.5%w/w | |||
PEG-40 CASTOR OIL | ORAL | TABLET | 61791126 | 4ERD2076EF | 9mg | ||
PEG-40 SORBITAN DIISOSTEARATE | DENTAL | SOLUTION | 58205962 | JL4CCU7I1G | 0.8%w/v | ||
PEG-40 SORBITAN DIISOSTEARATE | ORAL | LIQUID | 58205962 | JL4CCU7I1G | 100mg/15ml | ||
PEG-5 OLEATE | ORAL | SOLUTION | 9004960 | 0240V77G50 | 300mg/1ml | ||
PEG-5 OLEATE | TOPICAL | CREAM | 9004960 | 0240V77G50 | 98mg | ||
PEG-5 OLEATE | TOPICAL | LOTION | 9004960 | 0240V77G50 | NA | ||
PEG-5 OLEATE | VAGINAL | CREAM | 9004960 | 0240V77G50 | 3%w/w | ||
PEG-5 OLEATE | VAGINAL | SUPPOSITORY | 9004960 | 0240V77G50 | 30mg | ||
PEG-6 ISOSTEARATE | TOPICAL | LOTION | 56002143 | 0E2639OTJY | 143mg | ||
PEG-60 HYDROGENATED CASTOR OIL | INTRAVENOUS | INJECTION | 61788850 | 02NG325BQG | 20%w/v | ||
PEG-60 HYDROGENATED CASTOR OIL | TOPICAL | CREAM | 61788850 | 02NG325BQG | 1.9%w/w | ||
PEG-60 HYDROGENATED CASTOR OIL | TOPICAL | GEL | 61788850 | 02NG325BQG | 1.9%w/w | ||
PEG-7 LINOLEOYL GLYCERIDES | ORAL | CAPSULE | 993L8OB0ER | 300mg | |||
PEG-75 LANOLIN | TOPICAL | AEROSOL | 61790816 | 09179OX7TB | 1.5%w/w | ||
PEG-75 LANOLIN | TOPICAL | EMULSION | 61790816 | 09179OX7TB | 1.5%w/w | ||
PEG-75 LANOLIN | TOPICAL | SOLUTION | 61790816 | 09179OX7TB | 1%w/w | ||
PEG-8 LAURATE | TOPICAL | LOTION | 9004813 | 762O8IWA10 | 0.5%w/v | ||
PEG-8 LAURATE | TOPICAL | SUSPENSION | 9004813 | 762O8IWA10 | 0.63%w/w | ||
PEG-8 MONOSTEARATE | ORAL | CONCENTRATE | 9004993 | 2P9L47VI5E | 25mg/5ml | ||
PEG-8 MONOSTEARATE | ORAL | SUSPENSION | 9004993 | 2P9L47VI5E | 60mg | ||
PEG-8 MONOSTEARATE | TOPICAL | CREAM | 9004993 | 2P9L47VI5E | 229mg | ||
PEG-8 MONOSTEARATE | TOPICAL | SPONGE | 9004993 | 2P9L47VI5E | NA | ||
PEGOXOL 7 STEARATE | TOPICAL | CREAM | 3EW5AXE5X5 | 640mg | |||
PEGOXOL 7 STEARATE | TOPICAL | LOTION | 3EW5AXE5X5 | NA | |||
PEGOXOL 7 STEARATE | VAGINAL | CREAM | 3EW5AXE5X5 | 20%w/w | |||
PEGOXOL 7 STEARATE | VAGINAL | SUPPOSITORY | 3EW5AXE5X5 | 200mg | |||
PENTADECALACTONE | TRANSDERMAL | GEL | 106025 | OK17S3S98K | 8%w/w | ||
PENTAERYTHRITOL COCOATE | TOPICAL | OINTMENT | NA | 1%w/w | |||
PENTASODIUM PENTETATE | INTRAVENOUS | INJECTION | 140012 | 961TOZ5L7T | 5mg | ||
PENTASODIUM PENTETATE | TOPICAL | SOAP | 140012 | 961TOZ5L7T | NA | ||
PENTETIC ACID | INTRAVENOUS | INJECTION | 67436 | 7A314HQM0I | 2mg | ||
PEPPERMINT OIL | BUCCAL | FILM | 8006904 | AV092KU4JH | 12mg | Y | |
PEPPERMINT OIL | BUCCAL | FILM, SOLUBLE | 8006904 | AV092KU4JH | 3mg | ||
PEPPERMINT OIL | BUCCAL | GUM, CHEWING | 8006904 | AV092KU4JH | 526mg | ||
PEPPERMINT OIL | DENTAL | PASTE, DENTIFRICE | 8006904 | AV092KU4JH | 49.3%w/w | ||
PEPPERMINT OIL | DENTAL | POWDER, DENTIFRICE | 8006904 | AV092KU4JH | NA | ||
PEPPERMINT OIL | DENTAL | SOLUTION | 8006904 | AV092KU4JH | 0.04%v/v | ||
PEPPERMINT OIL | ORAL | CAPSULE | 8006904 | AV092KU4JH | 60mg | ||
PEPPERMINT OIL | ORAL | CONCENTRATE | 8006904 | AV092KU4JH | 0.05mg | ||
PEPPERMINT OIL | ORAL | ELIXIR | 8006904 | AV092KU4JH | 0.04mg/1ml | ||
PEPPERMINT OIL | ORAL | GUM, CHEWING | 8006904 | AV092KU4JH | 526mg | ||
PEPPERMINT OIL | ORAL | LOZENGE | 8006904 | AV092KU4JH | 12mg | ||
PEPPERMINT OIL | ORAL | SOLUTION | 8006904 | AV092KU4JH | 16mg | Y | |
PEPPERMINT OIL | ORAL | SUSPENSION | 8006904 | AV092KU4JH | 100mg/1ml | ||
PEPPERMINT OIL | ORAL | SYRUP | 8006904 | AV092KU4JH | 0.6ml/5ml | ||
PEPPERMINT OIL | ORAL | TABLET | 8006904 | AV092KU4JH | 28mg | ||
PEPPERMINT OIL | ORAL | TABLET, ORALLY DISINTEGRATING | 8006904 | AV092KU4JH | 3mg | ||
PEPPERMINT OIL | SUBLINGUAL | POWDER | 8006904 | AV092KU4JH | 1mg | ||
PEPPERMINT OIL | SUBLINGUAL | SPRAY, METERED | 8006904 | AV092KU4JH | 1mg | ||
PEPPERMINT OIL | SUBLINGUAL | TABLET | 8006904 | AV092KU4JH | 0.15mg | ||
PEPPERMINT OIL | TOPICAL | OINTMENT | 8006904 | AV092KU4JH | 0.2%w/w | ||
PEPPERMINT OIL | TOPICAL | SHAMPOO | 8006904 | AV092KU4JH | 0.2%w/w | ||
PERFUME GD 5604 | TOPICAL | CREAM | NA | 0.12%w/w | |||
PETROLATUM | AURICULAR (OTIC) | OINTMENT | 8009038 | 4T6H12BN9U | NA | ||
PETROLATUM | OPHTHALMIC | OINTMENT | 8009038 | 4T6H12BN9U | 88.4%w/w | ||
PETROLATUM | ORAL | CAPSULE, EXTENDED RELEASE | 8009038 | 4T6H12BN9U | 0.07mg | ||
PETROLATUM | ORAL | TABLET | 8009038 | 4T6H12BN9U | 3.5mg | ||
PETROLATUM | ORAL | TABLET, EXTENDED RELEASE | 8009038 | 4T6H12BN9U | 0.18mg | ||
PETROLATUM | RECTAL | OINTMENT | 8009038 | 4T6H12BN9U | 75%w/w | ||
PETROLATUM | RESPIRATORY (INHALATION) | LIQUID | 8009038 | 4T6H12BN9U | NA | ||
PETROLATUM | TOPICAL | AEROSOL, FOAM | 8009038 | 4T6H12BN9U | 7.9%w/w | ||
PETROLATUM | TOPICAL | CREAM | 8009038 | 4T6H12BN9U | 4213mg | ||
PETROLATUM | TOPICAL | CREAM, AUGMENTED | 8009038 | 4T6H12BN9U | 26%w/w | ||
PETROLATUM | TOPICAL | EMULSION | 8009038 | 4T6H12BN9U | 7.8%w/w | ||
PETROLATUM | TOPICAL | LOTION | 8009038 | 4T6H12BN9U | 25%w/w | ||
PETROLATUM | TOPICAL | OINTMENT | 8009038 | 4T6H12BN9U | 7275mg | ||
PETROLATUM | TOPICAL | OINTMENT, AUGMENTED | 8009038 | 4T6H12BN9U | 81.94%w/w | ||
PETROLATUM | TOPICAL | SOAP | 8009038 | 4T6H12BN9U | 0.85%w/w | ||
PETROLATUM | TOPICAL | SPONGE | 8009038 | 4T6H12BN9U | NA | ||
PETROLATUM | VAGINAL | CAPSULE | 8009038 | 4T6H12BN9U | NA | ||
PETROLATUM | VAGINAL | OINTMENT | 8009038 | 4T6H12BN9U | 88.49%w/w | ||
PETROLATUM | VAGINAL | SUPPOSITORY | 8009038 | 4T6H12BN9U | 27mg | ||
PHARMABURST B1 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 671.13mg | |||
PHARMABURST B2 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 792mg | |||
PHARMABURST B2 | SUBLINGUAL | TABLET | NA | 132.75mg | |||
PHARMABURST C1 | ORAL | TABLET, ORALLY DISINTEGRATING | NA | 817mg | |||
PHENAZOPYRIDINE HYDROCHLORIDE | ORAL | SYRUP | 136403 | 0EWG668W17 | NA | ||
PHENOL | INTRA-ARTICULAR | INJECTION | 108952 | 339NCG44TV | 0.5%w/v | ||
PHENOL | INTRADERMAL | INJECTION | 108952 | 339NCG44TV | 0.25%w/v | ||
PHENOL | INTRALESIONAL | INJECTION | 108952 | 339NCG44TV | 0.5%w/v | ||
PHENOL | INTRAMUSCULAR | INJECTION | 108952 | 339NCG44TV | 48mg | Y | |
PHENOL | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 108952 | 339NCG44TV | 2mg | ||
PHENOL | INTRAMUSCULAR | INJECTION, SOLUTION | 108952 | 339NCG44TV | 75mg | ||
PHENOL | INTRASYNOVIAL | INJECTION | 108952 | 339NCG44TV | 0.5%w/v | ||
PHENOL | INTRAVENOUS | INJECTION | 108952 | 339NCG44TV | 45mg | ||
PHENOL | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 108952 | 339NCG44TV | 2mg | ||
PHENOL | INTRAVENOUS | INJECTION, SOLUTION | 108952 | 339NCG44TV | 75mg | ||
PHENOL | INTRAVENOUS | LIQUID | 108952 | 339NCG44TV | 0.5%w/v | ||
PHENOL | INTRAVENOUS | SOLUTION | 108952 | 339NCG44TV | 23mg | ||
PHENOL | OPHTHALMIC | DROPS | 108952 | 339NCG44TV | 0.01%w/w | ||
PHENOL | SUBCUTANEOUS | INJECTION | 108952 | 339NCG44TV | 48mg | Y | |
PHENOL | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 108952 | 339NCG44TV | 2mg | ||
PHENOL | SUBCUTANEOUS | INJECTION, SOLUTION | 108952 | 339NCG44TV | 0.55%w/v | ||
PHENOL | SUBCUTANEOUS | INJECTION, SUSPENSION | 108952 | 339NCG44TV | 0.07%w/v | ||
PHENOL | SUBCUTANEOUS | LIQUID | 108952 | 339NCG44TV | 0.5%w/v | ||
PHENOL | VAGINAL | DOUCHE | 108952 | 339NCG44TV | 0.14%w/w | ||
PHENONIP | IONTOPHORESIS | SYSTEM | NA | 0.23mg | |||
PHENONIP | TOPICAL | GEL | NA | 0.04%w/w | |||
PHENONIP | TOPICAL | SYSTEM | NA | 0.23mg | |||
PHENOXYETHANOL | TOPICAL | AEROSOL | 122996 | HIE492ZZ3T | 1.05%w/w | ||
PHENOXYETHANOL | TOPICAL | AEROSOL, FOAM | 122996 | HIE492ZZ3T | 72mg | ||
PHENOXYETHANOL | TOPICAL | CREAM | 122996 | HIE492ZZ3T | 57mg | ||
PHENOXYETHANOL | TOPICAL | CREAM, AUGMENTED | 122996 | HIE492ZZ3T | 10mg | ||
PHENOXYETHANOL | TOPICAL | GEL | 122996 | HIE492ZZ3T | 14mg | ||
PHENOXYETHANOL | TOPICAL | LOTION | 122996 | HIE492ZZ3T | 1%w/w | ||
PHENYLALANINE | INTRAVENOUS | INJECTION | 63912 | 47E5O17Y3R | 7.26mg | ||
PHENYLALANINE | INTRAVENOUS | INJECTION, SOLUTION | 63912 | 47E5O17Y3R | 0.17%w/v | ||
PHENYLETHYL ALCOHOL | AURICULAR (OTIC) | SOLUTION | 60128 | ML9LGA7468 | 0.25%w/w | ||
PHENYLETHYL ALCOHOL | INTRA-ARTICULAR | SUSPENSION | 60128 | ML9LGA7468 | 5mg | ||
PHENYLETHYL ALCOHOL | INTRAMUSCULAR | SUSPENSION | 60128 | ML9LGA7468 | 5mg | ||
PHENYLETHYL ALCOHOL | NASAL | SPRAY | 60128 | ML9LGA7468 | 1mg | ||
PHENYLETHYL ALCOHOL | NASAL | SPRAY, METERED | 60128 | ML9LGA7468 | 2mg | ||
PHENYLETHYL ALCOHOL | OPHTHALMIC | SOLUTION | 60128 | ML9LGA7468 | 0.25%w/w | ||
PHENYLETHYL ALCOHOL | RESPIRATORY (INHALATION) | INHALANT | 60128 | ML9LGA7468 | 277.1mg | ||
PHENYLETHYL ALCOHOL | TOPICAL | CREAM | 60128 | ML9LGA7468 | NA | ||
PHENYLETHYL ALCOHOL | VAGINAL | CREAM | 60128 | ML9LGA7468 | NA | ||
PHENYLMERCURIC ACETATE | NASAL | DROPS | 62384 | OSX88361UX | 20mg | ||
PHENYLMERCURIC ACETATE | NASAL | SOLUTION | 62384 | OSX88361UX | 0.02mg/1ml | ||
PHENYLMERCURIC ACETATE | OPHTHALMIC | OINTMENT | 62384 | OSX88361UX | NA | ||
PHENYLMERCURIC ACETATE | OPHTHALMIC | SOLUTION | 62384 | OSX88361UX | NA | ||
PHENYLMERCURIC ACETATE | TOPICAL | CREAM | 62384 | OSX88361UX | 0.01%w/w | ||
PHENYLMERCURIC ACETATE | TOPICAL | SHAMPOO | 62384 | OSX88361UX | 0.02%w/w | ||
PHENYLMERCURIC ACETATE | VAGINAL | CREAM | 62384 | OSX88361UX | 0.01%w/w | ||
PHENYLMERCURIC NITRATE | NASAL | SOLUTION | 55685 | CG8692ZN14 | 2mg | ||
PHENYLMERCURIC NITRATE | OPHTHALMIC | OINTMENT | 55685 | CG8692ZN14 | NA | ||
PHENYLMERCURIC NITRATE | OPHTHALMIC | SOLUTION | 55685 | CG8692ZN14 | NA | ||
PHENYLMERCURIC NITRATE | ORAL | SOLUTION | 55685 | CG8692ZN14 | 0.03mg/1ml | ||
PHENYLMERCURIC NITRATE | ORAL | SYRUP | 55685 | CG8692ZN14 | 0.01mg/1ml | ||
PHOSPHOLIPID | INTRAVENOUS | INJECTION | NA | NA | |||
PHOSPHOLIPID | INTRAVENOUS | INJECTION, EMULSION | NA | 120mg | |||
PHOSPHOLIPID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NA | 120mg | |||
PHOSPHORIC ACID | DENTAL | PASTE, DENTIFRICE | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRA-ARTICULAR | INJECTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRALESIONAL | INJECTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRAMUSCULAR | INJECTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRAVENOUS | INJECTION | 7664382 | E4GA8884NN | 2.11%w/v | ||
PHOSPHORIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | OPHTHALMIC | SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | OPHTHALMIC | SOLUTION/ DROPS | 7664382 | E4GA8884NN | ADJ PH | Y | |
PHOSPHORIC ACID | ORAL | LIQUID | 7664382 | E4GA8884NN | NA | ||
PHOSPHORIC ACID | ORAL | SOLUTION | 7664382 | E4GA8884NN | 19mg | ||
PHOSPHORIC ACID | ORAL | SYRUP | 7664382 | E4GA8884NN | 6.4mg/5ml | ||
PHOSPHORIC ACID | ORAL | TABLET | 7664382 | E4GA8884NN | 0.04mg | ||
PHOSPHORIC ACID | ORAL | TABLET, EXTENDED RELEASE | 7664382 | E4GA8884NN | 0.19mg | ||
PHOSPHORIC ACID | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7664382 | E4GA8884NN | 6mg | ||
PHOSPHORIC ACID | ORAL | TABLET, ORALLY DISINTEGRATING | 7664382 | E4GA8884NN | 4mg | ||
PHOSPHORIC ACID | SOFT TISSUE | INJECTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | SUBCUTANEOUS | INJECTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | TOPICAL | CREAM | 7664382 | E4GA8884NN | 13mg | ||
PHOSPHORIC ACID | TOPICAL | CREAM, AUGMENTED | 7664382 | E4GA8884NN | 0.02%w/w | ||
PHOSPHORIC ACID | TOPICAL | GEL | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | TOPICAL | LOTION | 7664382 | E4GA8884NN | 1mg | ||
PHOSPHORIC ACID | TOPICAL | LOTION, AUGMENTED | 7664382 | E4GA8884NN | 1mg | ||
PHOSPHORIC ACID | TOPICAL | OINTMENT | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | TOPICAL | SOLUTION | 7664382 | E4GA8884NN | 0.23%w/w | ||
PHOSPHORIC ACID | TOPICAL | SPONGE | 7664382 | E4GA8884NN | ADJ PH | ||
PHOSPHORIC ACID | VAGINAL | AEROSOL, FOAM | 7664382 | E4GA8884NN | NA | ||
PHOSPHORIC ACID | VAGINAL | CREAM | 7664382 | E4GA8884NN | 0.56%w/w | ||
PIGMENT BLEND PB-2417 PINK | ORAL | TABLET | NA | 1.75mg | |||
PIGMENT BLEND PB-2417 PINK | ORAL | TABLET, EXTENDED RELEASE | NA | 0.7mg | |||
PIGMENTED POLYETHYLENE/POLYESTER 1501 FILM | TRANSDERMAL | SYSTEM | NA | 81mg | |||
PINE NEEDLE OIL (PINUS SYLVESTRIS) | TOPICAL | LOTION | 8023992 | 5EXL5H740Y | 0.25%w/w | ||
PINEAPPLE | ORAL | CONCENTRATE | 2A88ZO081O | 1mg/1ml | |||
PINEAPPLE | ORAL | POWDER, FOR SUSPENSION | 2A88ZO081O | 120mg | |||
PIPERAZINE | ORAL | TABLET | 110850 | 1RTM4PAL0V | 0.4mg | ||
PLASACRYL T20 | ORAL | CAPSULE, EXTENDED RELEASE | U3HKX3SA66 | 4mg | |||
PLASACRYL T20 | ORAL | TABLET | U3HKX3SA66 | 11mg | |||
PLASTIBASE-50W | TOPICAL | OINTMENT | NA | 99.95%w/w | |||
POLACRILIN | ORAL | TABLET | 50602216 | RCZ785HI7S | 3mg | ||
POLACRILIN | ORAL | TABLET, CHEWABLE | 50602216 | RCZ785HI7S | 20mg | ||
POLACRILIN | ORAL | TABLET, ORALLY DISINTEGRATING | 50602216 | RCZ785HI7S | 64mg | ||
POLACRILIN POTASSIUM | ORAL | CAPSULE | 65405552 | 0BZ5A00FQU | 78mg | ||
POLACRILIN POTASSIUM | ORAL | SOLUTION | 65405552 | 0BZ5A00FQU | 35mg | ||
POLACRILIN POTASSIUM | ORAL | SUSPENSION | 65405552 | 0BZ5A00FQU | 120mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET | 65405552 | 0BZ5A00FQU | 45.8mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET, CHEWABLE | 65405552 | 0BZ5A00FQU | 21mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET, COATED | 65405552 | 0BZ5A00FQU | 5mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET, EXTENDED RELEASE | 65405552 | 0BZ5A00FQU | 10mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET, FILM COATED | 65405552 | 0BZ5A00FQU | 40mg | ||
POLACRILIN POTASSIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 65405552 | 0BZ5A00FQU | 160mg | ||
POLIDRONIUM CHLORIDE | OPHTHALMIC | SOLUTION | 75345276 | 6716Z5YR3G | NA | ||
POLISHING SOLUTION IM-182 | ORAL | TABLET | NA | 0.7mg | |||
POLOXAMER 124 | ORAL | SUSPENSION | 691397134 | 1S66E28KXA | 0.09mg/1ml | ||
POLOXAMER 124 | TOPICAL | GEL | 691397134 | 1S66E28KXA | 4mg | ||
POLOXAMER 124 | TOPICAL | LOTION | 691397134 | 1S66E28KXA | 0.2%w/w | ||
POLOXAMER 182 | TOPICAL | GEL | 691397134 | JX0HIX6OAG | 4mg | ||
POLOXAMER 188 | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 691397134 | LQA7B6G8JG | 4mg | ||
POLOXAMER 188 | INTRAMUSCULAR | POWDER, FOR SUSPENSION | 691397134 | LQA7B6G8JG | 0.2%w/v | ||
POLOXAMER 188 | INTRAVENOUS | INJECTION | 691397134 | LQA7B6G8JG | 6mg | ||
POLOXAMER 188 | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 691397134 | LQA7B6G8JG | 2.2mg | ||
POLOXAMER 188 | OPHTHALMIC | SOLUTION | 691397134 | LQA7B6G8JG | 0.1%w/v | ||
POLOXAMER 188 | ORAL | CAPSULE | 691397134 | LQA7B6G8JG | 151mg | ||
POLOXAMER 188 | ORAL | CAPSULE, DELAYED RELEASE | 691397134 | LQA7B6G8JG | 18mg | ||
POLOXAMER 188 | ORAL | CONCENTRATE | 691397134 | LQA7B6G8JG | 3mg | ||
POLOXAMER 188 | ORAL | GRANULE | 691397134 | LQA7B6G8JG | 81mg | ||
POLOXAMER 188 | ORAL | GRANULE, FOR SOLUTION | 691397134 | LQA7B6G8JG | 624mg | ||
POLOXAMER 188 | ORAL | POWDER, FOR SOLUTION | 691397134 | LQA7B6G8JG | 500mg | ||
POLOXAMER 188 | ORAL | POWDER, FOR SUSPENSION | 691397134 | LQA7B6G8JG | 30mg | ||
POLOXAMER 188 | ORAL | SOLUTION | 691397134 | LQA7B6G8JG | 1800mg | ||
POLOXAMER 188 | ORAL | SUSPENSION | 691397134 | LQA7B6G8JG | 1600mg | ||
POLOXAMER 188 | ORAL | SUSPENSION, EXTENDED RELEASE | 691397134 | LQA7B6G8JG | 6mg | ||
POLOXAMER 188 | ORAL | TABLET | 691397134 | LQA7B6G8JG | 100mg | ||
POLOXAMER 188 | ORAL | TABLET, COATED | 691397134 | LQA7B6G8JG | 3mg | ||
POLOXAMER 188 | ORAL | TABLET, DELAYED RELEASE | 691397134 | LQA7B6G8JG | 6mg | ||
POLOXAMER 188 | ORAL | TABLET, EXTENDED RELEASE | 691397134 | LQA7B6G8JG | 37mg | ||
POLOXAMER 188 | ORAL | TABLET, FILM COATED | 691397134 | LQA7B6G8JG | 93mg | ||
POLOXAMER 188 | PERIODONTAL | GEL | 691397134 | LQA7B6G8JG | 55mg | ||
POLOXAMER 188 | TOPICAL | CREAM | 691397134 | LQA7B6G8JG | 1%w/w | ||
POLOXAMER 331 | ORAL | POWDER, FOR SOLUTION | 691397134 | IS93EQR73R | 1000mg/5ml | ||
POLOXAMER 331 | ORAL | POWDER, FOR SUSPENSION | 691397134 | IS93EQR73R | 26.43mg/5ml | ||
POLOXAMER 331 | ORAL | SUSPENSION | 691397134 | IS93EQR73R | 12.5mg/5ml | ||
POLOXAMER 407 | INTRATYMPANIC | SUSPENSION | 691397134 | TUF2IVW3M2 | 15.1%w/w | ||
POLOXAMER 407 | OPHTHALMIC | GEL | 691397134 | TUF2IVW3M2 | 1mg | ||
POLOXAMER 407 | OPHTHALMIC | SOLUTION | 691397134 | TUF2IVW3M2 | 0.2%w/v | ||
POLOXAMER 407 | OPHTHALMIC | SUSPENSION/ DROPS | 691397134 | TUF2IVW3M2 | 1mg | ||
POLOXAMER 407 | ORAL | CAPSULE | 691397134 | TUF2IVW3M2 | 468mg | ||
POLOXAMER 407 | ORAL | CAPSULE, DELAYED RELEASE | 691397134 | TUF2IVW3M2 | 5mg | ||
POLOXAMER 407 | ORAL | CAPSULE, EXTENDED RELEASE | 691397134 | TUF2IVW3M2 | 40mg | ||
POLOXAMER 407 | ORAL | POWDER, FOR SUSPENSION | 691397134 | TUF2IVW3M2 | 0.01mg | ||
POLOXAMER 407 | ORAL | SOLUTION | 691397134 | TUF2IVW3M2 | 50mg/5ml | ||
POLOXAMER 407 | ORAL | SUSPENSION | 691397134 | TUF2IVW3M2 | 10mg | ||
POLOXAMER 407 | ORAL | TABLET | 691397134 | TUF2IVW3M2 | 495mg | ||
POLOXAMER 407 | ORAL | TABLET, FILM COATED | 691397134 | TUF2IVW3M2 | 106.7mg | ||
POLOXAMER 407 | PERIODONTAL | GEL | 691397134 | TUF2IVW3M2 | 155mg | ||
POLOXAMER 407 | TOPICAL | CREAM | 691397134 | TUF2IVW3M2 | 1%w/w | ||
POLOXAMER 407 | TOPICAL | GEL | 691397134 | TUF2IVW3M2 | 28mg | ||
POLOXAMER 407 | TOPICAL | LOTION | 691397134 | TUF2IVW3M2 | 1%w/w | ||
POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 26936243 | 99Q3C7L77T | 88mg | ||
POLYACRYLIC ACID (250000 MW) | TOPICAL | SYSTEM | 9003014 | 9G2MAD7J6W | 196mg | ||
POLYACRYLIC ACID (250000 MW) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003014 | 9G2MAD7J6W | NA | ||
POLYBUTENE (1400 MW) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003296 | 1NA5AO9GH7 | NA | ||
POLYBUTENE (1400 MW) | TRANSDERMAL | SYSTEM | 9003296 | 1NA5AO9GH7 | 17.87mg | ||
POLYCARBOPHIL | BUCCAL | FILM | 9003978 | W25LM17A4W | 2mg | ||
POLYCARBOPHIL | BUCCAL | FILM, SOLUBLE | 9003978 | W25LM17A4W | 6mg | ||
POLYCARBOPHIL | BUCCAL | TABLET | 9003978 | W25LM17A4W | 6mg | ||
POLYCARBOPHIL | OPHTHALMIC | GEL | 9003978 | W25LM17A4W | 0.38%w/w | ||
POLYCARBOPHIL | OPHTHALMIC | SOLUTION | 9003978 | W25LM17A4W | 0.9%w/w | ||
POLYCARBOPHIL | OPHTHALMIC | SUSPENSION/ DROPS | 9003978 | W25LM17A4W | 0.86%w/v | ||
POLYCARBOPHIL | TOPICAL | GEL | 9003978 | W25LM17A4W | 2%w/w | ||
POLYCARBOPHIL | TOPICAL | SYSTEM | 9003978 | W25LM17A4W | 14mg | ||
POLYDEXTROSE | ORAL | TABLET | 68424044 | VH2XOU12IE | 20mg | ||
POLYDEXTROSE | ORAL | TABLET, COATED | 68424044 | VH2XOU12IE | 7.67mg | ||
POLYDEXTROSE | ORAL | TABLET, EXTENDED RELEASE | 68424044 | VH2XOU12IE | 22mg | Y | |
POLYDEXTROSE | ORAL | TABLET, FILM COATED | 68424044 | VH2XOU12IE | 18mg | ||
POLYDEXTROSE K | ORAL | TABLET, FILM COATED | NA | 8.13mg | |||
POLYESTER | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 24mg | |||
POLYESTER | TRANSDERMAL | SYSTEM | NA | 2001mg | |||
POLYESTER | VAGINAL | INSERT, EXTENDED RELEASE | NA | NA | |||
POLYESTER POLYAMINE COPOLYMER | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 6.67mg | |||
POLYETHYLENE GLYCOL 1000 | ORAL | CONCENTRATE | 25322683 | U076Q6Q621 | 100mg/1ml | ||
POLYETHYLENE GLYCOL 1000 | ORAL | SOLUTION | 25322683 | U076Q6Q621 | 1000mg/5ml | ||
POLYETHYLENE GLYCOL 1000 | ORAL | TABLET, FILM COATED | 25322683 | U076Q6Q621 | 1.52mg | ||
POLYETHYLENE GLYCOL 1000 | RECTAL | SUPPOSITORY | 25322683 | U076Q6Q621 | 1658mg | ||
POLYETHYLENE GLYCOL 1000 | TOPICAL | AEROSOL, FOAM | 25322683 | U076Q6Q621 | NA | ||
POLYETHYLENE GLYCOL 1000 | TOPICAL | CREAM | 25322683 | U076Q6Q621 | 0.5%w/w | ||
POLYETHYLENE GLYCOL 1000 | TOPICAL | GEL | 25322683 | U076Q6Q621 | 50mg | ||
POLYETHYLENE GLYCOL 1000 | TRANSDERMAL | GEL | 25322683 | U076Q6Q621 | 0.5%w/w | ||
POLYETHYLENE GLYCOL 1000 | VAGINAL | SUPPOSITORY | 25322683 | U076Q6Q621 | NA | ||
POLYETHYLENE GLYCOL 1450 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | OJ4Z5Z32L4 | 91mg | ||
POLYETHYLENE GLYCOL 1450 | ORAL | SOLUTION | 25322683 | OJ4Z5Z32L4 | 6108mg | ||
POLYETHYLENE GLYCOL 1450 | ORAL | SUSPENSION | 25322683 | OJ4Z5Z32L4 | 4000mg | ||
POLYETHYLENE GLYCOL 1450 | ORAL | TABLET | 25322683 | OJ4Z5Z32L4 | 0.6mg | ||
POLYETHYLENE GLYCOL 1450 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | OJ4Z5Z32L4 | 9mg | ||
POLYETHYLENE GLYCOL 1450 | ORAL | TABLET, FILM COATED | 25322683 | OJ4Z5Z32L4 | 0.13mg | ||
POLYETHYLENE GLYCOL 1450 | TOPICAL | OINTMENT | 25322683 | OJ4Z5Z32L4 | 921mg | ||
POLYETHYLENE GLYCOL 1450 | URETHRAL | SUPPOSITORY | 25322683 | OJ4Z5Z32L4 | 9.75mg | ||
POLYETHYLENE GLYCOL 1600 | DENTAL | GEL | 25322683 | 1212Z7S33A | 5%w/w | ||
POLYETHYLENE GLYCOL 1600 | DENTAL | PASTE | 25322683 | 1212Z7S33A | 4.96%w/w | ||
POLYETHYLENE GLYCOL 1600 | ORAL | TABLET | 25322683 | 1212Z7S33A | 1.2mg | ||
POLYETHYLENE GLYCOL 1600 | ORAL | TABLET, COATED | 25322683 | 1212Z7S33A | NA | ||
POLYETHYLENE GLYCOL 1600 | RECTAL | SUPPOSITORY | 25322683 | 1212Z7S33A | 0.3mg/mg | ||
POLYETHYLENE GLYCOL 1600 | TOPICAL | SOLUTION | 25322683 | 1212Z7S33A | 29.7%w/w | ||
POLYETHYLENE GLYCOL 200 | AURICULAR (OTIC) | DROPS | 112607 | R95B8J264J | 9.98%w/w | ||
POLYETHYLENE GLYCOL 200 | ORAL | CAPSULE | 112607 | R95B8J264J | NA | ||
POLYETHYLENE GLYCOL 200 | ORAL | SOLUTION | 112607 | R95B8J264J | 200mg/1ml | ||
POLYETHYLENE GLYCOL 200 | TOPICAL | OINTMENT | 112607 | R95B8J264J | 39%w/w | ||
POLYETHYLENE GLYCOL 20000 | ORAL | CAPSULE | 25322683 | 5WKN5KL2O8 | 108mg | ||
POLYETHYLENE GLYCOL 20000 | ORAL | TABLET | 25322683 | 5WKN5KL2O8 | 6mg | ||
POLYETHYLENE GLYCOL 20000 | ORAL | TABLET, DELAYED RELEASE | 25322683 | 5WKN5KL2O8 | 0.01mg | ||
POLYETHYLENE GLYCOL 300 | AURICULAR (OTIC) | DROPS | 25322683 | 5655G9Y8AQ | 97.43%w/w | ||
POLYETHYLENE GLYCOL 300 | INTRAMUSCULAR | INJECTION | 25322683 | 5655G9Y8AQ | 50%v/v | ||
POLYETHYLENE GLYCOL 300 | INTRAMUSCULAR | SOLUTION | 25322683 | 5655G9Y8AQ | 16920mg | ||
POLYETHYLENE GLYCOL 300 | INTRAVENOUS | INJECTION | 25322683 | 5655G9Y8AQ | 2768mg | ||
POLYETHYLENE GLYCOL 300 | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 25322683 | 5655G9Y8AQ | 44.22%w/v | ||
POLYETHYLENE GLYCOL 300 | INTRAVENOUS | LIQUID | 25322683 | 5655G9Y8AQ | 5850mg | ||
POLYETHYLENE GLYCOL 300 | INTRAVENOUS | SOLUTION | 25322683 | 5655G9Y8AQ | 16920mg | ||
POLYETHYLENE GLYCOL 300 | OPHTHALMIC | OINTMENT | 25322683 | 5655G9Y8AQ | NA | ||
POLYETHYLENE GLYCOL 300 | ORAL | TABLET | 25322683 | 5655G9Y8AQ | 1mg | ||
POLYETHYLENE GLYCOL 300 | ORAL | TABLET, FILM COATED | 25322683 | 5655G9Y8AQ | 2mg | ||
POLYETHYLENE GLYCOL 300 | TOPICAL | CREAM | 25322683 | 5655G9Y8AQ | 4%w/w | ||
POLYETHYLENE GLYCOL 300 | TOPICAL | OINTMENT | 25322683 | 5655G9Y8AQ | 1114mg | ||
POLYETHYLENE GLYCOL 300 | TOPICAL | SOLUTION | 25322683 | 5655G9Y8AQ | 29.7%w/w | ||
POLYETHYLENE GLYCOL 3000 | ORAL | TABLET | 25322683 | SA1B764746 | 8mg | ||
POLYETHYLENE GLYCOL 3000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | SA1B764746 | 24mg | ||
POLYETHYLENE GLYCOL 3350 | INTRA-ARTICULAR | INJECTION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRA-ARTICULAR | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRALESIONAL | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 60mg | ||
POLYETHYLENE GLYCOL 3350 | INTRASYNOVIAL | INJECTION | 25322683 | G2M7P15E5P | 3%w/v | ||
POLYETHYLENE GLYCOL 3350 | INTRASYNOVIAL | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | INTRAVENOUS | INJECTION | 25322683 | G2M7P15E5P | 0.5ml | ||
POLYETHYLENE GLYCOL 3350 | NASAL | SOLUTION | 25322683 | G2M7P15E5P | 40000mg/100ml | ||
POLYETHYLENE GLYCOL 3350 | ORAL | CAPSULE | 25322683 | G2M7P15E5P | 576mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 51mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | SUSPENSION | 25322683 | G2M7P15E5P | 45mg/1ml | ||
POLYETHYLENE GLYCOL 3350 | ORAL | SUSPENSION, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 37mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET | 25322683 | G2M7P15E5P | 52mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, CHEWABLE | 25322683 | G2M7P15E5P | 15mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, COATED | 25322683 | G2M7P15E5P | 0.5mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, DELAYED RELEASE | 25322683 | G2M7P15E5P | 18mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 61mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, FILM COATED | 25322683 | G2M7P15E5P | 20mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | G2M7P15E5P | 8.5mg | ||
POLYETHYLENE GLYCOL 3350 | ORAL | TABLET, ORALLY DISINTEGRATING | 25322683 | G2M7P15E5P | 0.08mg | ||
POLYETHYLENE GLYCOL 3350 | RECTAL | SUPPOSITORY | 25322683 | G2M7P15E5P | 1425.96mg | ||
POLYETHYLENE GLYCOL 3350 | SOFT TISSUE | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 56mg | ||
POLYETHYLENE GLYCOL 3350 | SUBCUTANEOUS | INJECTION, SUSPENSION | 25322683 | G2M7P15E5P | 2.88%w/v | ||
POLYETHYLENE GLYCOL 3350 | SUBCUTANEOUS | SUSPENSION | 25322683 | G2M7P15E5P | 2.88%w/v | ||
POLYETHYLENE GLYCOL 3350 | TOPICAL | CREAM | 25322683 | G2M7P15E5P | 396mg | ||
POLYETHYLENE GLYCOL 3350 | TOPICAL | OINTMENT | 25322683 | G2M7P15E5P | 990mg | ||
POLYETHYLENE GLYCOL 3350 | VAGINAL | SUPPOSITORY | 25322683 | G2M7P15E5P | NA | ||
POLYETHYLENE GLYCOL 3500 | ORAL | TABLET | 25322683 | FVS1AZD90Y | 3.05mg | ||
POLYETHYLENE GLYCOL 400 | INTRAMUSCULAR | INJECTION | 25322683 | B697894SGQ | 20.3%w/v | ||
POLYETHYLENE GLYCOL 400 | INTRAMUSCULAR | INJECTION, SOLUTION | 25322683 | B697894SGQ | 18%v/v | ||
POLYETHYLENE GLYCOL 400 | INTRAVENOUS | INJECTION | 25322683 | B697894SGQ | 28216mg | ||
POLYETHYLENE GLYCOL 400 | INTRAVENOUS | INJECTION, SOLUTION | 25322683 | B697894SGQ | 28217mg | ||
POLYETHYLENE GLYCOL 400 | NASAL | SPRAY, METERED | 25322683 | B697894SGQ | 200mg/1ml | ||
POLYETHYLENE GLYCOL 400 | OPHTHALMIC | SOLUTION | 25322683 | B697894SGQ | 46mg | ||
POLYETHYLENE GLYCOL 400 | OPHTHALMIC | SOLUTION/ DROPS | 25322683 | B697894SGQ | 1%w/v | ||
POLYETHYLENE GLYCOL 400 | ORAL | CAPSULE | 25322683 | B697894SGQ | 13440mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | CAPSULE, DELAYED RELEASE | 25322683 | B697894SGQ | 26mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | B697894SGQ | 17mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | CAPSULE, LIQUID FILLED | 25322683 | B697894SGQ | 1122mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | CONCENTRATE | 25322683 | B697894SGQ | 3000mg | Y | |
POLYETHYLENE GLYCOL 400 | ORAL | FILM, SOLUBLE | 25322683 | B697894SGQ | 4.76mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | SOLUTION | 25322683 | B697894SGQ | 24000mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | SOLUTION, CONCENTRATE | 25322683 | B697894SGQ | 2813mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | SUSPENSION | 25322683 | B697894SGQ | 400mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | SYRUP | 25322683 | B697894SGQ | 740mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET | 25322683 | B697894SGQ | 193mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET, DELAYED RELEASE | 25322683 | B697894SGQ | 35mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | B697894SGQ | 45mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET, FILM COATED | 25322683 | B697894SGQ | 20mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | B697894SGQ | 2mg | ||
POLYETHYLENE GLYCOL 400 | ORAL | TABLET, ORALLY DISINTEGRATING | 25322683 | B697894SGQ | 2mg | ||
POLYETHYLENE GLYCOL 400 | RECTAL | SUPPOSITORY | 25322683 | B697894SGQ | 0.25mg/mg | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | AEROSOL, POWDER | 25322683 | B697894SGQ | NA | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | CREAM | 25322683 | B697894SGQ | 7.5%w/w | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | EMULSION | 25322683 | B697894SGQ | 1.2%w/w | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | GEL | 25322683 | B697894SGQ | 6300mg | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | LIQUID | 25322683 | B697894SGQ | 1%w/w | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | LOTION | 25322683 | B697894SGQ | 5%w/w | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | OINTMENT | 25322683 | B697894SGQ | 1950mg | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | SOLUTION | 25322683 | B697894SGQ | 11100mg | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | SPONGE | 25322683 | B697894SGQ | NA | ||
POLYETHYLENE GLYCOL 400 | TOPICAL | SWAB | 25322683 | B697894SGQ | 5250mg | ||
POLYETHYLENE GLYCOL 400 | VAGINAL | SUPPOSITORY | 25322683 | B697894SGQ | 30mg | ||
POLYETHYLENE GLYCOL 4000 | DENTAL | OINTMENT | 25322683 | 4R4HFI6D95 | NA | ||
POLYETHYLENE GLYCOL 4000 | INTRA-ARTICULAR | INJECTION | 25322683 | 4R4HFI6D95 | 3%w/v | ||
POLYETHYLENE GLYCOL 4000 | INTRAMUSCULAR | INJECTION | 25322683 | 4R4HFI6D95 | 3%w/v | ||
POLYETHYLENE GLYCOL 4000 | INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 25322683 | 4R4HFI6D95 | 75mg | ||
POLYETHYLENE GLYCOL 4000 | INTRASYNOVIAL | INJECTION | 25322683 | 4R4HFI6D95 | 3%w/v | ||
POLYETHYLENE GLYCOL 4000 | INTRAVENOUS | INJECTION, SUSPENSION | 25322683 | 4R4HFI6D95 | 0.49%w/v | ||
POLYETHYLENE GLYCOL 4000 | ORAL | CAPSULE | 25322683 | 4R4HFI6D95 | 1659mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | CAPSULE, DELAYED RELEASE | 25322683 | 4R4HFI6D95 | 1.28mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | 4R4HFI6D95 | 10.72mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | GRANULE | 25322683 | 4R4HFI6D95 | 83mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | SOLUTION | 25322683 | 4R4HFI6D95 | 2667mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | SYRUP | 25322683 | 4R4HFI6D95 | 370mg/5ml | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET | 25322683 | 4R4HFI6D95 | 83mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET, COATED | 25322683 | 4R4HFI6D95 | 2mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET, DELAYED RELEASE | 25322683 | 4R4HFI6D95 | 120mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 4R4HFI6D95 | 90mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET, FILM COATED | 25322683 | 4R4HFI6D95 | 5mg | ||
POLYETHYLENE GLYCOL 4000 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | 4R4HFI6D95 | 2mg | ||
POLYETHYLENE GLYCOL 4000 | RECTAL | SUPPOSITORY | 25322683 | 4R4HFI6D95 | 1269mg | ||
POLYETHYLENE GLYCOL 4000 | SUBLINGUAL | TABLET | 25322683 | 4R4HFI6D95 | 2.5mg | ||
POLYETHYLENE GLYCOL 4000 | TOPICAL | OINTMENT | 25322683 | 4R4HFI6D95 | 45%w/w | ||
POLYETHYLENE GLYCOL 4000 | TOPICAL | SOLUTION | 25322683 | 4R4HFI6D95 | NA | ||
POLYETHYLENE GLYCOL 4000 | VAGINAL | CREAM | 25322683 | 4R4HFI6D95 | 0.5%w/w | ||
POLYETHYLENE GLYCOL 4000 | VAGINAL | SUPPOSITORY | 25322683 | 4R4HFI6D95 | NA | ||
POLYETHYLENE GLYCOL 4500 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | TVH7653921 | 53mg | ||
POLYETHYLENE GLYCOL 540 | TOPICAL | OINTMENT | 25322683 | NA | 1639mg | ||
POLYETHYLENE GLYCOL 600 | INTRAVENOUS | INJECTION | 25322683 | NL4J9F21N9 | 5%w/v | ||
POLYETHYLENE GLYCOL 600 | INTRAVENOUS | INJECTION, SOLUTION | 25322683 | NL4J9F21N9 | 5%w/v | ||
POLYETHYLENE GLYCOL 600 | ORAL | CAPSULE | 25322683 | NL4J9F21N9 | 1742mg | ||
POLYETHYLENE GLYCOL 600 | ORAL | CAPSULE, LIQUID FILLED | 25322683 | NL4J9F21N9 | 1584mg | ||
POLYETHYLENE GLYCOL 600 | ORAL | SOLUTION | 25322683 | NL4J9F21N9 | 650mg/5ml | ||
POLYETHYLENE GLYCOL 600 | ORAL | TABLET | 25322683 | NL4J9F21N9 | 6mg | ||
POLYETHYLENE GLYCOL 600 | ORAL | TABLET, DELAYED RELEASE | 25322683 | NL4J9F21N9 | NA | ||
POLYETHYLENE GLYCOL 600 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | NL4J9F21N9 | 2.5mg | ||
POLYETHYLENE GLYCOL 600 | TOPICAL | SOLUTION | 25322683 | NL4J9F21N9 | 0.3%w/w | ||
POLYETHYLENE GLYCOL 6000 | BUCCAL | TABLET | 25322683 | 30IQX730WE | 70mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | CAPSULE | 25322683 | 30IQX730WE | 3600mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | CAPSULE, DELAYED RELEASE | 25322683 | 30IQX730WE | 35mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 25322683 | 30IQX730WE | 135mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | 30IQX730WE | 302mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET | 25322683 | 30IQX730WE | 750mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, COATED | 25322683 | 30IQX730WE | 106mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, DELAYED RELEASE | 25322683 | 30IQX730WE | 120mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 30IQX730WE | 250mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, FILM COATED | 25322683 | 30IQX730WE | 132mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | 30IQX730WE | 0.5mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 25322683 | 30IQX730WE | 20mg | ||
POLYETHYLENE GLYCOL 6000 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 25322683 | 30IQX730WE | 69mg | ||
POLYETHYLENE GLYCOL 6000 | RECTAL | SUPPOSITORY | 25322683 | 30IQX730WE | 128mg | ||
POLYETHYLENE GLYCOL 6000 | SUBLINGUAL | TABLET | 25322683 | 30IQX730WE | 70mg | ||
POLYETHYLENE GLYCOL 6000 | TOPICAL | CREAM | 25322683 | 30IQX730WE | 5%w/w | ||
POLYETHYLENE GLYCOL 6000 | VAGINAL | INSERT | 25322683 | 30IQX730WE | 0.06mg | ||
POLYETHYLENE GLYCOL 800 | ORAL | TABLET | 25322683 | UH6KR4953D | 3.48mg | ||
POLYETHYLENE GLYCOL 8000 | OPHTHALMIC | SOLUTION | 25322683 | Q662QK8M3B | 2%w/w | ||
POLYETHYLENE GLYCOL 8000 | ORAL | CAPSULE | 25322683 | Q662QK8M3B | 180mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | CAPSULE, EXTENDED RELEASE | 25322683 | Q662QK8M3B | 98mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET | 25322683 | Q662QK8M3B | 1200mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, CHEWABLE | 25322683 | Q662QK8M3B | 6.5mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, COATED | 25322683 | Q662QK8M3B | 0.21mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, DELAYED RELEASE | 25322683 | Q662QK8M3B | 29mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | Q662QK8M3B | 242mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, FILM COATED | 25322683 | Q662QK8M3B | 49mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | Q662QK8M3B | 14mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, ORALLY DISINTEGRATING | 25322683 | Q662QK8M3B | 1mg | ||
POLYETHYLENE GLYCOL 8000 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 25322683 | Q662QK8M3B | 8mg | ||
POLYETHYLENE GLYCOL 8000 | RECTAL | SUPPOSITORY | 25322683 | Q662QK8M3B | 52mg | ||
POLYETHYLENE GLYCOL 8000 | SUBLINGUAL | FILM | 25322683 | Q662QK8M3B | 24mg | ||
POLYETHYLENE GLYCOL 8000 | TOPICAL | CREAM | 25322683 | Q662QK8M3B | 361mg | ||
POLYETHYLENE GLYCOL 8000 | TOPICAL | POWDER | 25322683 | Q662QK8M3B | NA | ||
POLYETHYLENE GLYCOL 8000 | TOPICAL | SOLUTION | 25322683 | Q662QK8M3B | NA | ||
POLYETHYLENE GLYCOL 900 | TOPICAL | SOLUTION | 25322683 | UEP843BRCQ | 0.95%w/w | ||
POLYETHYLENE GLYCOL MONOMETHYL ETHER 350 | TOPICAL | GEL | 9004744 | ENK4Y6S66X | 400mg | ||
POLYETHYLENE OXIDE 100000 | ORAL | FILM, SOLUBLE | 25322683 | V46Y6OJ5QB | 52mg | ||
POLYETHYLENE OXIDE 100000 | ORAL | TABLET | 25322683 | V46Y6OJ5QB | 192.66mg | ||
POLYETHYLENE OXIDE 100000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | V46Y6OJ5QB | 96.33mg | ||
POLYETHYLENE OXIDE 100000 | SUBLINGUAL | FILM | 25322683 | V46Y6OJ5QB | 18mg | ||
POLYETHYLENE OXIDE 1000000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | HZ58M6D839 | 30mg | ||
POLYETHYLENE OXIDE 1000000 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25322683 | HZ58M6D839 | 336mg | ||
POLYETHYLENE OXIDE 200000 | ORAL | FILM, SOLUBLE | 25322683 | 11628IH70O | 107mg | ||
POLYETHYLENE OXIDE 200000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 11628IH70O | 463mg | ||
POLYETHYLENE OXIDE 200000 | SUBLINGUAL | FILM | 25322683 | 11628IH70O | 41mg | ||
POLYETHYLENE OXIDE 2000000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 5K3991GVWI | 550mg | ||
POLYETHYLENE OXIDE 4000000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | RU64142H6P | 276mg | ||
POLYETHYLENE OXIDE 5000000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 3IG9032SAH | 272mg | ||
POLYETHYLENE OXIDE 600000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 2126FD486L | 189mg | ||
POLYETHYLENE OXIDE 7000000 | ORAL | TABLET | 25322683 | G3MS6M810Y | 265mg | ||
POLYETHYLENE OXIDE 7000000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | G3MS6M810Y | 371mg | ||
POLYETHYLENE OXIDE 900000 | ORAL | TABLET, EXTENDED RELEASE | 25322683 | 16P9295IIL | 1287mg | ||
POLYETHYLENE OXIDE 900000 | SUBLINGUAL | FILM | 25322683 | 16P9295IIL | 18mg | ||
POLYGLACTIN | DENTAL | POWDER | 26780507 | NA | NA | ||
POLYGLACTIN | INTRAMUSCULAR | INJECTION | 26780507 | NA | 132.4mg | ||
POLYGLACTIN | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 26780507 | NA | 33mg | ||
POLYGLACTIN | INTRAMUSCULAR | INJECTION, SUSPENSION | 26780507 | NA | 138mg | ||
POLYGLACTIN | INTRAMUSCULAR | POWDER, FOR SUSPENSION | 26780507 | NA | 28.32%w/v | ||
POLYGLACTIN | SUBCUTANEOUS | IMPLANT | 26780507 | NA | 25.2mg | ||
POLYGLACTIN | SUBCUTANEOUS | INJECTION | 26780507 | NA | 211.5mg | ||
POLYGLACTIN | SUBCUTANEOUS | INJECTION, POWDER, FOR SUSPENSION | 26780507 | NA | 132.6mg | ||
POLYGLACTIN | SUBCUTANEOUS | INJECTION, SUSPENSION | 26780507 | NA | 304mg | ||
POLYGLACTIN | SUBCUTANEOUS | PELLET, IMPLANTABLE | 26780507 | NA | 4mg | ||
POLYGLYCERYL-3 OLEATE | ORAL | CAPSULE | 33940986 | XRQ165498B | 2mg | ||
POLYGLYCERYL-3 OLEATE | ORAL | SOLUTION | 33940986 | XRQ165498B | 310mg/1ml | ||
POLYGLYCERYL-3 OLEATE | TOPICAL | CREAM | 33940986 | XRQ165498B | 2.7%w/w | ||
POLYGLYCERYL-3 OLEATE | VAGINAL | CREAM | 33940986 | XRQ165498B | 135mg | Y | |
POLYISOBUTYLENE | TOPICAL | SYSTEM | 9003274 | NA | 270.06mg | ||
POLYISOBUTYLENE | TRANSDERMAL | FILM | 9003274 | NA | 17mg | ||
POLYISOBUTYLENE | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003274 | NA | 615.4mg | ||
POLYISOBUTYLENE | TRANSDERMAL | SYSTEM | 9003274 | NA | 42.1mg | ||
POLYISOBUTYLENE (1100000 MW) | TOPICAL | SYSTEM | 9003274 | FLT10CH37X | 67mg | ||
POLYISOBUTYLENE (1100000 MW) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003274 | FLT10CH37X | 69mg | ||
POLYISOBUTYLENE (1100000 MW) | TRANSDERMAL | SYSTEM | 9003274 | FLT10CH37X | 23mg | ||
POLYISOBUTYLENE (55000 MW) | TRANSDERMAL | FILM | 9003274 | TQ77WR8A02 | 238.44mg | ||
POLYISOBUTYLENE (55000 MW) | TRANSDERMAL | SYSTEM | 9003274 | TQ77WR8A02 | 29.8mg | ||
POLYISOBUTYLENE/POLYBUTENE ADHESIVE | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 221.25mg | |||
POLYLACTIDE | INTRAMUSCULAR | INJECTION | 26680104 | 459TN2L5F5 | 99mg | ||
POLYLACTIDE | INTRAVENOUS | INJECTION | 26680104 | 459TN2L5F5 | 264.8mg | ||
POLYLACTIDE | PERIODONTAL | SYSTEM | 26680104 | 459TN2L5F5 | 0.37mg/mg | ||
POLYLACTIDE (14000 MW) | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 9J7G894K2M | 188mg | |||
POLYOXYETHYLENE ALCOHOLS | TOPICAL | CREAM | 9007630 | NA | 7.5%w/w | ||
POLYOXYETHYLENE ALCOHOLS | TOPICAL | OINTMENT | 9007630 | NA | NA | ||
POLYOXYETHYLENE FATTY ACID ESTERS | INTRAMUSCULAR | INJECTION | NA | 14%w/v | |||
POLYOXYETHYLENE FATTY ACID ESTERS | SUBCUTANEOUS | INJECTION | NA | 14%w/v | |||
POLYOXYETHYLENE FATTY ACID ESTERS | TOPICAL | CREAM | NA | 1.9%w/w | |||
POLYOXYETHYLENE FATTY ACID ESTERS | TOPICAL | DISC | NA | NA | |||
POLYOXYL 15 HYDROXYSTEARATE | INTRAVENOUS | INJECTION, EMULSION | 70142346 | 71YMM1X75O | 4.4%w/v | ||
POLYOXYL 15 HYDROXYSTEARATE | OPHTHALMIC | EMULSION | 70142346 | 71YMM1X75O | 0.25%w/v | ||
POLYOXYL 20 CETOSTEARYL ETHER | ORAL | SUSPENSION | 68439496 | YRC528SWUY | 20mg | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | AEROSOL | 68439496 | YRC528SWUY | 5.5%w/w | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | AEROSOL, FOAM | 68439496 | YRC528SWUY | 374mg | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | CREAM | 68439496 | YRC528SWUY | 180mg | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | GEL | 68439496 | YRC528SWUY | 2%w/w | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | LOTION | 68439496 | YRC528SWUY | 71mg | ||
POLYOXYL 20 CETOSTEARYL ETHER | TOPICAL | SPRAY | 68439496 | YRC528SWUY | 2.42%w/w | ||
POLYOXYL 35 CASTOR OIL | INTRAMUSCULAR | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 1750mg | ||
POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION | 61791126 | 6D4M1DAL6O | 27668mg | ||
POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 350mg | ||
POLYOXYL 35 CASTOR OIL | INTRAVENOUS | INJECTION, SOLUTION | 61791126 | 6D4M1DAL6O | 52.75%w/v | ||
POLYOXYL 35 CASTOR OIL | INTRAVESICAL | SOLUTION | 61791126 | 6D4M1DAL6O | 10588mg | ||
POLYOXYL 35 CASTOR OIL | OPHTHALMIC | SOLUTION | 61791126 | 6D4M1DAL6O | 5%w/v | ||
POLYOXYL 35 CASTOR OIL | OPHTHALMIC | SOLUTION/ DROPS | 61791126 | 6D4M1DAL6O | 5%w/v | ||
POLYOXYL 35 CASTOR OIL | ORAL | CAPSULE | 61791126 | 6D4M1DAL6O | 1170mg | ||
POLYOXYL 35 CASTOR OIL | ORAL | SOLUTION | 61791126 | 6D4M1DAL6O | 515mg/1ml | ||
POLYOXYL 35 CASTOR OIL | ORAL | SUSPENSION | 61791126 | 6D4M1DAL6O | 0.4mg/1ml | ||
POLYOXYL 35 CASTOR OIL | ORAL | TABLET | 61791126 | 6D4M1DAL6O | 4mg | ||
POLYOXYL 35 CASTOR OIL | ORAL | TABLET, EXTENDED RELEASE | 61791126 | 6D4M1DAL6O | 5.2mg | ||
POLYOXYL 35 CASTOR OIL | SUBCUTANEOUS | INJECTION, EMULSION | 61791126 | 6D4M1DAL6O | 1750mg | ||
POLYOXYL 35 CASTOR OIL | SUBLINGUAL | TABLET | 61791126 | 6D4M1DAL6O | 4mg | ||
POLYOXYL 35 CASTOR OIL | TOPICAL | CREAM | 61791126 | 6D4M1DAL6O | 4%w/w | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | DENTAL | SOLUTION | 61788850 | 7YC686GQ8F | 1%w/w | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | OPHTHALMIC | SOLUTION | 61788850 | 7YC686GQ8F | 3mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | OPHTHALMIC | SOLUTION/ DROPS | 61788850 | 7YC686GQ8F | 0.53%w/v | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | CAPSULE | 61788850 | 7YC686GQ8F | 3319mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | CAPSULE, COATED | 61788850 | 7YC686GQ8F | 101.25mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | LIQUID | 61788850 | 7YC686GQ8F | 102mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | SOLUTION | 61788850 | 7YC686GQ8F | 450mg/1ml | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | TABLET | 61788850 | 7YC686GQ8F | 120mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | ORAL | TABLET, EXTENDED RELEASE | 61788850 | 7YC686GQ8F | 50mg | ||
POLYOXYL 40 HYDROGENATED CASTOR OIL | TOPICAL | CREAM | 61788850 | 7YC686GQ8F | 1%w/w | ||
POLYOXYL 40 STEARATE TYPE I | AURICULAR (OTIC) | SUSPENSION | 13A4J4NH9I | 1%w/v | |||
POLYOXYL 40 STEARATE TYPE I | OPHTHALMIC | OINTMENT | 13A4J4NH9I | NA | |||
POLYOXYL 40 STEARATE TYPE I | OPHTHALMIC | SOLUTION | 13A4J4NH9I | 7%w/w | |||
POLYOXYL 40 STEARATE TYPE I | OPHTHALMIC | SUSPENSION | 13A4J4NH9I | 0.5%w/v | |||
POLYOXYL 40 STEARATE TYPE I | ORAL | CAPSULE | 13A4J4NH9I | 7mg | Y | ||
POLYOXYL 40 STEARATE TYPE I | ORAL | GRANULE | 13A4J4NH9I | NA | |||
POLYOXYL 40 STEARATE TYPE I | ORAL | TABLET | 13A4J4NH9I | 8.48mg | |||
POLYOXYL 40 STEARATE TYPE I | ORAL | TABLET, FILM COATED | 13A4J4NH9I | 2mg | |||
POLYOXYL 40 STEARATE TYPE I | TOPICAL | AEROSOL, FOAM | 13A4J4NH9I | 2.83%w/w | |||
POLYOXYL 40 STEARATE TYPE I | TOPICAL | CREAM | 13A4J4NH9I | 50mg | Y | ||
POLYOXYL 40 STEARATE TYPE I | TOPICAL | LOTION | 13A4J4NH9I | 3%w/w | |||
POLYOXYL 40 STEARATE TYPE I | TOPICAL | OINTMENT | 13A4J4NH9I | NA | |||
POLYOXYL 40 STEARATE TYPE I | TOPICAL | SPONGE | 13A4J4NH9I | NA | |||
POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE | TOPICAL | CREAM | NA | 20%w/w | |||
POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE | TOPICAL | LOTION | NA | 5%w/w | |||
POLYOXYL DISTEARATE | TOPICAL | OINTMENT | 9005087 | NA | NA | ||
POLYOXYL GLYCERYL STEARATE | ORAL | TABLET | NA | 23.33mg | |||
POLYOXYL GLYCERYL STEARATE | TOPICAL | LOTION | NA | 1.5%w/w | |||
POLYOXYL STEARATE | AURICULAR (OTIC) | SUSPENSION | NA | 0.01%w/w | |||
POLYOXYL STEARATE | ORAL | SUSPENSION | NA | 40mg | |||
POLYOXYL STEARATE | ORAL | TABLET, COATED | NA | 2mg | |||
POLYOXYL STEARATE | TOPICAL | AEROSOL, FOAM | NA | 4.36%w/w | |||
POLYOXYL STEARATE | TOPICAL | CREAM | NA | 70mg | |||
POLYOXYL STEARATE | TOPICAL | EMULSION | NA | NA | |||
POLYOXYL STEARATE | TOPICAL | LOTION | NA | 2%w/w | |||
POLYOXYL STEARATE | VAGINAL | CREAM | NA | 0.25%w/w | |||
POLYPROPYLENE | TOPICAL | SPONGE | 9003070 | NA | 22.68%w/w | ||
POLYPROPYLENE | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003070 | NA | 13.5mg | ||
POLYPROPYLENE | TRANSDERMAL | SYSTEM | 9003070 | NA | 151.4mg | ||
POLYPROPYLENE GLYCOL | OPHTHALMIC | SOLUTION | 9003150 | NA | 15%w/w | ||
POLYPROPYLENE GLYCOL | ORAL | SOLUTION | 9003150 | NA | 1000mg/5ml | ||
POLYPROPYLENE GLYCOL | ORAL | SUSPENSION | 9003150 | NA | NA | ||
POLYPROPYLENE GLYCOL | ORAL | TABLET | 9003150 | NA | 1.26mg | ||
POLYPROPYLENE GLYCOL | TOPICAL | LIQUID | 9003150 | NA | 1.7%w/w | ||
POLYPROPYLENE GLYCOL | TOPICAL | LOTION | 9003150 | NA | 1179mg | ||
POLYPROPYLENE GLYCOL 11 STEARYL ETHER | TOPICAL | AEROSOL, FOAM | 25231214 | S4G2J0Y0LG | 5%w/w | ||
POLYPROPYLENE GLYCOL 11 STEARYL ETHER | TOPICAL | SUSPENSION | 25231214 | S4G2J0Y0LG | 2288mg | ||
POLYPROPYLENE GLYCOL 15 STEARYL ETHER | TOPICAL | GEL | 25231214 | 1II18XLS1L | 2%w/w | ||
POLYPROPYLENE GLYCOL 15 STEARYL ETHER | TOPICAL | OINTMENT | 25231214 | 1II18XLS1L | 15%w/w | ||
POLYPROPYLENE GLYCOL 15 STEARYL ETHER | TOPICAL | SUSPENSION | 25231214 | 1II18XLS1L | 16%w/w | ||
POLYQUATERNIUM-10 | TOPICAL | SHAMPOO | 81859247 | NA | 2%w/w | ||
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) | TOPICAL | SHAMPOO | 26590056 | 0L414VCS5Y | 1%w/w | ||
POLYSILOXANE | INTRAVENOUS | INJECTION | 9014135 | NA | NA | ||
POLYSILOXANE | ORAL | CAPSULE | 9014135 | NA | NA | ||
POLYSORB 85/70/00 | ORAL | CAPSULE | NA | 432mg | |||
POLYSORB 85/70/00 | ORAL | CAPSULE, LIQUID FILLED | NA | 161mg | |||
POLYSORBATE 20 | AURICULAR (OTIC) | SUSPENSION | 9005645 | 7T1F30V5YH | 0.1%w/v | ||
POLYSORBATE 20 | INTRAMUSCULAR | INJECTION | 9005645 | 7T1F30V5YH | 1.62%w/v | ||
POLYSORBATE 20 | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 9005645 | 7T1F30V5YH | 60mg | ||
POLYSORBATE 20 | INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 9005645 | 7T1F30V5YH | 60mg | ||
POLYSORBATE 20 | INTRAVENOUS | INJECTION | 9005645 | 7T1F30V5YH | 30mg | ||
POLYSORBATE 20 | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 9005645 | 7T1F30V5YH | NA | ||
POLYSORBATE 20 | INTRAVENOUS | INJECTION, SOLUTION | 9005645 | 7T1F30V5YH | 30mg | ||
POLYSORBATE 20 | NASAL | SPRAY, METERED | 9005645 | 7T1F30V5YH | 25mg/1ml | ||
POLYSORBATE 20 | OPHTHALMIC | SUSPENSION | 9005645 | 7T1F30V5YH | 0.05%w/v | ||
POLYSORBATE 20 | ORAL | CAPSULE | 9005645 | 7T1F30V5YH | 563mg | ||
POLYSORBATE 20 | ORAL | POWDER, FOR SUSPENSION | 9005645 | 7T1F30V5YH | 1.3mg/5ml | ||
POLYSORBATE 20 | ORAL | SUSPENSION | 9005645 | 7T1F30V5YH | 80mg | ||
POLYSORBATE 20 | ORAL | TABLET | 9005645 | 7T1F30V5YH | 17mg | ||
POLYSORBATE 20 | ORAL | TABLET, EXTENDED RELEASE | 9005645 | 7T1F30V5YH | 4.2mg | ||
POLYSORBATE 20 | ORAL | TABLET, FILM COATED | 9005645 | 7T1F30V5YH | 0.35mg | ||
POLYSORBATE 20 | SUBCUTANEOUS | INJECTION | 9005645 | 7T1F30V5YH | NA | ||
POLYSORBATE 20 | SUBCUTANEOUS | INJECTION, SOLUTION | 9005645 | 7T1F30V5YH | NA | ||
POLYSORBATE 20 | TOPICAL | AEROSOL, FOAM | 9005645 | 7T1F30V5YH | 3.7%w/w | ||
POLYSORBATE 20 | TOPICAL | CLOTH | 9005645 | 7T1F30V5YH | NA | ||
POLYSORBATE 20 | TOPICAL | CREAM | 9005645 | 7T1F30V5YH | 108mg | ||
POLYSORBATE 20 | TOPICAL | EMULSION | 9005645 | 7T1F30V5YH | 2%w/w | ||
POLYSORBATE 20 | TOPICAL | GEL | 9005645 | 7T1F30V5YH | 5%w/w | ||
POLYSORBATE 20 | TOPICAL | LOTION | 9005645 | 7T1F30V5YH | 2000mg | Y | |
POLYSORBATE 20 | TOPICAL | SHAMPOO | 9005645 | 7T1F30V5YH | 8%w/w | ||
POLYSORBATE 20 | TOPICAL | SOAP | 9005645 | 7T1F30V5YH | 0.02%w/w | ||
POLYSORBATE 20 | TOPICAL | SOLUTION | 9005645 | 7T1F30V5YH | 15%w/w | ||
POLYSORBATE 20 | VAGINAL | AEROSOL, FOAM | 9005645 | 7T1F30V5YH | 3%w/w | ||
POLYSORBATE 20 | VAGINAL | SUPPOSITORY | 9005645 | 7T1F30V5YH | NA | ||
POLYSORBATE 20 | VAGINAL | TAMPON | 9005645 | 7T1F30V5YH | 64.8mg | ||
POLYSORBATE 40 | ORAL | DROPS | 9005667 | STI11B5A2X | 0.02ml | ||
POLYSORBATE 40 | ORAL | ELIXIR | 9005667 | STI11B5A2X | 0.05mg/5ml | ||
POLYSORBATE 40 | ORAL | SUSPENSION | 9005667 | STI11B5A2X | NA | ||
POLYSORBATE 40 | TOPICAL | CREAM | 9005667 | STI11B5A2X | 3%w/w | ||
POLYSORBATE 40 | TOPICAL | GEL | 9005667 | STI11B5A2X | 28mg | ||
POLYSORBATE 40 | TOPICAL | LIQUID | 9005667 | STI11B5A2X | 2%w/w | ||
POLYSORBATE 40 | TOPICAL | LOTION | 9005667 | STI11B5A2X | 2%w/w | ||
POLYSORBATE 60 | BUCCAL | GUM, CHEWING | 9005678 | CAL22UVI4M | 5mg | ||
POLYSORBATE 60 | ORAL | EMULSION | 9005678 | CAL22UVI4M | 20mg/1ml | ||
POLYSORBATE 60 | ORAL | SUSPENSION | 9005678 | CAL22UVI4M | 25mg/5ml | ||
POLYSORBATE 60 | ORAL | TABLET, COATED | 9005678 | CAL22UVI4M | NA | ||
POLYSORBATE 60 | RECTAL | SUPPOSITORY | 9005678 | CAL22UVI4M | 0.05mg/mg | ||
POLYSORBATE 60 | TOPICAL | AEROSOL | 9005678 | CAL22UVI4M | 0.42%w/w | ||
POLYSORBATE 60 | TOPICAL | AEROSOL, FOAM | 9005678 | CAL22UVI4M | 30mg | ||
POLYSORBATE 60 | TOPICAL | CREAM | 9005678 | CAL22UVI4M | 225mg | ||
POLYSORBATE 60 | TOPICAL | CREAM, AUGMENTED | 9005678 | CAL22UVI4M | 3%w/w | ||
POLYSORBATE 60 | TOPICAL | LOTION | 9005678 | CAL22UVI4M | 5%w/w | ||
POLYSORBATE 60 | TOPICAL | OINTMENT | 9005678 | CAL22UVI4M | 2%w/w | ||
POLYSORBATE 60 | TOPICAL | SHAMPOO | 9005678 | CAL22UVI4M | 14.55%w/w | ||
POLYSORBATE 60 | TOPICAL | SUSPENSION | 9005678 | CAL22UVI4M | 2.85%w/w | ||
POLYSORBATE 60 | VAGINAL | CREAM | 9005678 | CAL22UVI4M | 5%w/w | ||
POLYSORBATE 60 | VAGINAL | SUPPOSITORY | 9005678 | CAL22UVI4M | 0.03mg | ||
POLYSORBATE 80 | AURICULAR (OTIC) | DROPS | 9005656 | 6OZP39ZG8H | 0.02%w/w | ||
POLYSORBATE 80 | AURICULAR (OTIC) | SOLUTION | 9005656 | 6OZP39ZG8H | 0.2%w/w | ||
POLYSORBATE 80 | AURICULAR (OTIC) | SOLUTION/ DROPS | 9005656 | 6OZP39ZG8H | 13mg | ||
POLYSORBATE 80 | AURICULAR (OTIC) | SUSPENSION | 9005656 | 6OZP39ZG8H | 1%w/v | ||
POLYSORBATE 80 | INTRA-ARTICULAR | INJECTION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRA-ARTICULAR | INJECTION, POWDER, FOR SUSPENSION | 9005656 | 6OZP39ZG8H | 5mg | ||
POLYSORBATE 80 | INTRA-ARTICULAR | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRALESIONAL | INJECTION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRALESIONAL | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRAMUSCULAR | INJECTION | 9005656 | 6OZP39ZG8H | 4%w/v | ||
POLYSORBATE 80 | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9005656 | 6OZP39ZG8H | 1mg | ||
POLYSORBATE 80 | INTRAMUSCULAR | INJECTION, SOLUTION | 9005656 | 6OZP39ZG8H | 5%w/v | ||
POLYSORBATE 80 | INTRAMUSCULAR | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRASYNOVIAL | INJECTION | 9005656 | 6OZP39ZG8H | 0.2%w/v | ||
POLYSORBATE 80 | INTRASYNOVIAL | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | INTRAVENOUS | CONCENTRATE | 9005656 | 6OZP39ZG8H | 4680mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION | 9005656 | 6OZP39ZG8H | 4680mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 9005656 | 6OZP39ZG8H | 53mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9005656 | 6OZP39ZG8H | 900mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION, SOLUTION | 9005656 | 6OZP39ZG8H | 1170mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 9005656 | 6OZP39ZG8H | 4739mg | ||
POLYSORBATE 80 | INTRAVENOUS | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 0.5%w/v | ||
POLYSORBATE 80 | INTRAVENOUS | LIQUID | 9005656 | 6OZP39ZG8H | 720mg | ||
POLYSORBATE 80 | INTRAVENOUS | SOLUTION | 9005656 | 6OZP39ZG8H | 900mg | ||
POLYSORBATE 80 | INTRAVITREAL | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 0.02%w/v | ||
POLYSORBATE 80 | NASAL | SPRAY | 9005656 | 6OZP39ZG8H | 0.01mg | ||
POLYSORBATE 80 | NASAL | SPRAY, METERED | 9005656 | 6OZP39ZG8H | 0.1mg/1ml | ||
POLYSORBATE 80 | OPHTHALMIC | DROPS | 9005656 | 6OZP39ZG8H | 0.05%w/w | ||
POLYSORBATE 80 | OPHTHALMIC | EMULSION | 9005656 | 6OZP39ZG8H | 26mg | ||
POLYSORBATE 80 | OPHTHALMIC | SOLUTION | 9005656 | 6OZP39ZG8H | 0.25%w/v | ||
POLYSORBATE 80 | OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 9005656 | 6OZP39ZG8H | 0.05%w/w | ||
POLYSORBATE 80 | OPHTHALMIC | SOLUTION/ DROPS | 9005656 | 6OZP39ZG8H | 0.15%w/v | ||
POLYSORBATE 80 | OPHTHALMIC | SUSPENSION | 9005656 | 6OZP39ZG8H | 0.1%w/w | ||
POLYSORBATE 80 | OPHTHALMIC | SUSPENSION/ DROPS | 9005656 | 6OZP39ZG8H | 0.1%w/w | ||
POLYSORBATE 80 | ORAL | CAPSULE | 9005656 | 6OZP39ZG8H | 418.37mg | ||
POLYSORBATE 80 | ORAL | CAPSULE, COATED | 9005656 | 6OZP39ZG8H | 0.04mg | ||
POLYSORBATE 80 | ORAL | CAPSULE, COATED PELLETS | 9005656 | 6OZP39ZG8H | 2mg | ||
POLYSORBATE 80 | ORAL | CAPSULE, DELAYED RELEASE | 9005656 | 6OZP39ZG8H | 23mg | ||
POLYSORBATE 80 | ORAL | CAPSULE, EXTENDED RELEASE | 9005656 | 6OZP39ZG8H | 10mg | ||
POLYSORBATE 80 | ORAL | CAPSULE, LIQUID FILLED | 9005656 | 6OZP39ZG8H | 24mg | ||
POLYSORBATE 80 | ORAL | CONCENTRATE | 9005656 | 6OZP39ZG8H | 1mg/1ml | ||
POLYSORBATE 80 | ORAL | ELIXIR | 9005656 | 6OZP39ZG8H | 2.5mg/15ml | ||
POLYSORBATE 80 | ORAL | GRANULE, FOR SUSPENSION | 9005656 | 6OZP39ZG8H | 240mg | ||
POLYSORBATE 80 | ORAL | PASTE | 9005656 | 6OZP39ZG8H | 28mg | ||
POLYSORBATE 80 | ORAL | POWDER | 9005656 | 6OZP39ZG8H | 66mg | ||
POLYSORBATE 80 | ORAL | POWDER, FOR SUSPENSION | 9005656 | 6OZP39ZG8H | 150mg | ||
POLYSORBATE 80 | ORAL | SOLUTION | 9005656 | 6OZP39ZG8H | 432mg | ||
POLYSORBATE 80 | ORAL | SUSPENSION | 9005656 | 6OZP39ZG8H | 206mg | ||
POLYSORBATE 80 | ORAL | SUSPENSION, EXTENDED RELEASE | 9005656 | 6OZP39ZG8H | 40mg | ||
POLYSORBATE 80 | ORAL | SUSPENSION/ DROPS | 9005656 | 6OZP39ZG8H | 23mg | ||
POLYSORBATE 80 | ORAL | TABLET | 9005656 | 6OZP39ZG8H | 233mg | ||
POLYSORBATE 80 | ORAL | TABLET, CHEWABLE | 9005656 | 6OZP39ZG8H | 0.02mg | ||
POLYSORBATE 80 | ORAL | TABLET, COATED | 9005656 | 6OZP39ZG8H | 18mg | ||
POLYSORBATE 80 | ORAL | TABLET, DELAYED RELEASE | 9005656 | 6OZP39ZG8H | 3mg | ||
POLYSORBATE 80 | ORAL | TABLET, EXTENDED RELEASE | 9005656 | 6OZP39ZG8H | 10mg | Y | |
POLYSORBATE 80 | ORAL | TABLET, FILM COATED | 9005656 | 6OZP39ZG8H | 24mg | ||
POLYSORBATE 80 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9005656 | 6OZP39ZG8H | 8mg | ||
POLYSORBATE 80 | ORAL | TABLET, ORALLY DISINTEGRATING | 9005656 | 6OZP39ZG8H | 1mg | ||
POLYSORBATE 80 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9005656 | 6OZP39ZG8H | 34mg | ||
POLYSORBATE 80 | RECTAL | ENEMA | 9005656 | 6OZP39ZG8H | 0.01%w/v | ||
POLYSORBATE 80 | RECTAL | SOLUTION | 9005656 | 6OZP39ZG8H | 315mg | ||
POLYSORBATE 80 | RECTAL | SUPPOSITORY | 9005656 | 6OZP39ZG8H | 72.15mg | ||
POLYSORBATE 80 | RESPIRATORY (INHALATION) | SUSPENSION | 9005656 | 6OZP39ZG8H | 1mg | ||
POLYSORBATE 80 | SOFT TISSUE | INJECTION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | SOFT TISSUE | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 4mg | ||
POLYSORBATE 80 | SUBCUTANEOUS | INJECTION, SUSPENSION | 9005656 | 6OZP39ZG8H | 0.3%w/v | ||
POLYSORBATE 80 | SUBCUTANEOUS | SUSPENSION | 9005656 | 6OZP39ZG8H | 0.3%w/v | ||
POLYSORBATE 80 | SUBLINGUAL | TABLET | 9005656 | 6OZP39ZG8H | 0.08mg | ||
POLYSORBATE 80 | TOPICAL | AEROSOL, FOAM | 9005656 | 6OZP39ZG8H | 0.98%w/w | ||
POLYSORBATE 80 | TOPICAL | CREAM | 9005656 | 6OZP39ZG8H | 20mg | ||
POLYSORBATE 80 | TOPICAL | EMULSION | 9005656 | 6OZP39ZG8H | 2.5%w/w | ||
POLYSORBATE 80 | TOPICAL | GEL | 9005656 | 6OZP39ZG8H | 12mg | ||
POLYSORBATE 80 | TOPICAL | LOTION | 9005656 | 6OZP39ZG8H | 15%w/w | ||
POLYSORBATE 80 | TOPICAL | OINTMENT | 9005656 | 6OZP39ZG8H | 0.1%w/w | ||
POLYSORBATE 80 | TOPICAL | SYSTEM | 9005656 | 6OZP39ZG8H | 126mg | ||
POLYSORBATE 80 | VAGINAL | AEROSOL, FOAM | 9005656 | 6OZP39ZG8H | 3%w/w | ||
POLYSORBATE 80 | VAGINAL | CREAM | 9005656 | 6OZP39ZG8H | 0.4%w/w | ||
POLYSORBATE 80 | VAGINAL | SUPPOSITORY | 9005656 | 6OZP39ZG8H | 28mg | ||
POLYSTYRENE SULFONIC ACID | ORAL | CAPSULE | 9002237 | 70KO0R01RY | 12mg | ||
POLYSTYRENE SULFONIC ACID | ORAL | CAPSULE, EXTENDED RELEASE | 9002237 | 70KO0R01RY | 32mg | ||
POLYSTYRENE SULFONIC ACID | ORAL | TABLET, ORALLY DISINTEGRATING | 9002237 | 70KO0R01RY | 86mg | Y | |
POLYVINYL ACETATE | ORAL | SUSPENSION | 9003207 | 32K497ZK2U | 122mg | ||
POLYVINYL ACETATE | ORAL | SUSPENSION, EXTENDED RELEASE | 9003207 | 32K497ZK2U | 92.9mg/5ml | ||
POLYVINYL ACETATE | ORAL | TABLET | 9003207 | 32K497ZK2U | 7mg | ||
POLYVINYL ACETATE | ORAL | TABLET, CHEWABLE | 9003207 | 32K497ZK2U | NA | ||
POLYVINYL ACETATE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 9003207 | 32K497ZK2U | 39mg | ||
POLYVINYL ACETATE | ORAL | TABLET, EXTENDED RELEASE | 9003207 | 32K497ZK2U | 225mg | ||
POLYVINYL ACETATE | ORAL | TABLET, ORALLY DISINTEGRATING | 9003207 | 32K497ZK2U | 6.5mg | ||
POLYVINYL ACETATE | SUBLINGUAL | TABLET | 9003207 | 32K497ZK2U | 8.07mg | ||
POLYVINYL ACETATE | TRANSDERMAL | SYSTEM | 9003207 | 32K497ZK2U | 16mg | ||
POLYVINYL ACETATE PHTHALATE | ORAL | CAPSULE | 34481486 | 58QVG85GW3 | NA | ||
POLYVINYL ACETATE PHTHALATE | ORAL | CAPSULE, EXTENDED RELEASE | 34481486 | 58QVG85GW3 | 32mg | ||
POLYVINYL ACETATE PHTHALATE | ORAL | TABLET, DELAYED RELEASE | 34481486 | 58QVG85GW3 | NA | ||
POLYVINYL ACETATE PHTHALATE | ORAL | TABLET, EXTENDED RELEASE | 34481486 | 58QVG85GW3 | 37.4mg | ||
POLYVINYL ALCOHOL | AURICULAR (OTIC) | SUSPENSION | 9002895 | 532B59J990 | 0.05%w/v | ||
POLYVINYL ALCOHOL | INTRAVITREAL | IMPLANT | 9002895 | 532B59J990 | 0.12mg | ||
POLYVINYL ALCOHOL | OPHTHALMIC | SOLUTION | 9002895 | 532B59J990 | 1.4%w/w | ||
POLYVINYL ALCOHOL | OPHTHALMIC | SOLUTION/ DROPS | 9002895 | 532B59J990 | 1.4%w/v | ||
POLYVINYL ALCOHOL | OPHTHALMIC | SUSPENSION | 9002895 | 532B59J990 | 1.4%w/w | ||
POLYVINYL ALCOHOL | OPHTHALMIC | SUSPENSION/ DROPS | 9002895 | 532B59J990 | 1.4%w/v | ||
POLYVINYL ALCOHOL | ORAL | CAPSULE | 9002895 | 532B59J990 | 1.67mg | ||
POLYVINYL ALCOHOL | ORAL | CAPSULE, EXTENDED RELEASE | 9002895 | 532B59J990 | 3.03mg | ||
POLYVINYL ALCOHOL | ORAL | SUSPENSION | 9002895 | 532B59J990 | 5mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET | 9002895 | 532B59J990 | 165mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, COATED | 9002895 | 532B59J990 | 0.7mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, DELAYED RELEASE | 9002895 | 532B59J990 | 35mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, EXTENDED RELEASE | 9002895 | 532B59J990 | 120mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, FILM COATED | 9002895 | 532B59J990 | 20mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9002895 | 532B59J990 | 3mg | ||
POLYVINYL ALCOHOL | ORAL | TABLET, ORALLY DISINTEGRATING | 9002895 | 532B59J990 | 6mg | ||
POLYVINYL ALCOHOL | TOPICAL | SOLUTION | 9002895 | 532B59J990 | 1.4%w/v | ||
POLYVINYL ALCOHOL | TOPICAL | SYSTEM | 9002895 | 532B59J990 | 420mg | ||
POLYVINYL ALCOHOL | VAGINAL | AEROSOL, FOAM | 9002895 | 532B59J990 | 0.5%w/w | ||
POLYVINYL ALCOHOL | VAGINAL | CREAM | 9002895 | 532B59J990 | 0.5%w/w | ||
POLYVINYL ALCOHOL (94000 MW) | ORAL | TABLET | 9002895 | C1MS7RRZ6L | 10mg | ||
POLYVINYL ALCOHOL (94000 MW) | ORAL | TABLET, EXTENDED RELEASE | 9002895 | C1MS7RRZ6L | 19mg | ||
POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET | 121786161 | 23ZQ42JZZH | 5.37mg | ||
POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET, EXTENDED RELEASE | 121786161 | 23ZQ42JZZH | 76mg | ||
POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 121786161 | 23ZQ42JZZH | 7mg | ||
POLYVINYL ALCOHOL/POLYVINYL ACETATE COPOLYMER (8:1; 18000 MW) | ORAL | TABLET, EXTENDED RELEASE | 9002895 | I5O20161WH | 9.2mg | ||
POLYVINYL CHLORIDE-POLYVINYL ACETATE COPOLYMER | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 899.88mg | |||
POLYVINYLACETAL | ORAL | CAPSULE, EXTENDED RELEASE | NA | 5mg | |||
POLYVINYLACETAL | ORAL | TABLET | NA | 419mg | |||
POTASSIUM ACETATE | RECTAL | ENEMA | 127082 | M911911U02 | 0.41%w/v | ||
POTASSIUM ALUM | VAGINAL | POWDER | 7784249 | 1L24V9R23S | 14mg | ||
POTASSIUM ALUM | VAGINAL | SUPPOSITORY | 7784249 | 1L24V9R23S | 17.2mg | ||
POTASSIUM BICARBONATE | BUCCAL | TABLET | 298146 | HM5Z15LEBN | 8mg | ||
POTASSIUM BICARBONATE | ORAL | CAPSULE | 298146 | HM5Z15LEBN | 174mg | ||
POTASSIUM BICARBONATE | ORAL | LOZENGE | 298146 | HM5Z15LEBN | 80mg | ||
POTASSIUM BICARBONATE | ORAL | POWDER, FOR SOLUTION | 298146 | HM5Z15LEBN | 1000mg | ||
POTASSIUM BICARBONATE | ORAL | SOLUTION | 298146 | HM5Z15LEBN | 125mg | ||
POTASSIUM BICARBONATE | ORAL | TABLET | 298146 | HM5Z15LEBN | 12.2mg | ||
POTASSIUM BICARBONATE | ORAL | TROCHE | 298146 | HM5Z15LEBN | 60mg | ||
POTASSIUM BICARBONATE | SUBLINGUAL | TABLET | 298146 | HM5Z15LEBN | 8mg | ||
POTASSIUM BITARTRATE | ORAL | TABLET, EXTENDED RELEASE | 868144 | NPT6P8P3UU | 10mg | ||
POTASSIUM BITARTRATE | VAGINAL | DOUCHE | 868144 | NPT6P8P3UU | 10%w/w | ||
POTASSIUM CARBONATE | ORAL | CAPSULE | 584087 | BQN1B9B9HA | 27.69mg | ||
POTASSIUM CARBONATE | ORAL | SOLUTION | 584087 | BQN1B9B9HA | 6.2mg/1ml | ||
POTASSIUM CARBONATE | ORAL | TABLET | 584087 | BQN1B9B9HA | 120mg | ||
POTASSIUM CARBONATE | TOPICAL | CREAM | 584087 | BQN1B9B9HA | NA | ||
POTASSIUM CARBONATE | TOPICAL | SOLUTION | 584087 | BQN1B9B9HA | 15%w/w | ||
POTASSIUM CHLORIDE | INFILTRATION | INJECTION | 7447407 | 660YQ98I10 | 0.3mg | ||
POTASSIUM CHLORIDE | INTRAMUSCULAR | INJECTION | 7447407 | 660YQ98I10 | 0.4mg | ||
POTASSIUM CHLORIDE | INTRAOCULAR | SOLUTION | 7447407 | 660YQ98I10 | 0.75mg | ||
POTASSIUM CHLORIDE | INTRATHECAL | INJECTION, SOLUTION | 7447407 | 660YQ98I10 | 1mg | ||
POTASSIUM CHLORIDE | INTRAVENOUS | INJECTION | 7447407 | 660YQ98I10 | 1mg | ||
POTASSIUM CHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | 7447407 | 660YQ98I10 | 0.44%w/v | ||
POTASSIUM CHLORIDE | INTRAVITREAL | INJECTION, SUSPENSION | 7447407 | 660YQ98I10 | 0.08%w/v | ||
POTASSIUM CHLORIDE | IRRIGATION | SOLUTION | 7447407 | 660YQ98I10 | 0.04%w/v | ||
POTASSIUM CHLORIDE | NASAL | POWDER | 7447407 | 660YQ98I10 | NA | ||
POTASSIUM CHLORIDE | OPHTHALMIC | SOLUTION | 7447407 | 660YQ98I10 | 0.22%w/v | ||
POTASSIUM CHLORIDE | OPHTHALMIC | SOLUTION/ DROPS | 7447407 | 660YQ98I10 | 0.14%w/v | ||
POTASSIUM CHLORIDE | OPHTHALMIC | SUSPENSION | 7447407 | 660YQ98I10 | 0.03%w/w | ||
POTASSIUM CHLORIDE | ORAL | CAPSULE | 7447407 | 660YQ98I10 | 62mg | ||
POTASSIUM CHLORIDE | ORAL | CAPSULE, DELAYED RELEASE | 7447407 | 660YQ98I10 | 2mg | ||
POTASSIUM CHLORIDE | ORAL | POWDER | 7447407 | 660YQ98I10 | 0.18mg | ||
POTASSIUM CHLORIDE | ORAL | SUSPENSION | 7447407 | 660YQ98I10 | NA | ||
POTASSIUM CHLORIDE | ORAL | TABLET | 7447407 | 660YQ98I10 | 231mg | ||
POTASSIUM CHLORIDE | ORAL | TABLET, EXTENDED RELEASE | 7447407 | 660YQ98I10 | 13mg | ||
POTASSIUM CHLORIDE | RESPIRATORY (INHALATION) | POWDER | 7447407 | 660YQ98I10 | 0.18mg | ||
POTASSIUM CHLORIDE | TOPICAL | SOAP | 7447407 | 660YQ98I10 | NA | ||
POTASSIUM CITRATE | ORAL | POWDER, FOR SOLUTION | 6100056 | EE90ONI6FF | 570mg | ||
POTASSIUM CITRATE | ORAL | SOLUTION | 6100056 | EE90ONI6FF | 913mg | ||
POTASSIUM CITRATE | ORAL | SUSPENSION | 6100056 | EE90ONI6FF | NA | ||
POTASSIUM CITRATE | TOPICAL | AEROSOL | 6100056 | EE90ONI6FF | 0.26%w/w | ||
POTASSIUM CITRATE | TOPICAL | AEROSOL, FOAM | 6100056 | EE90ONI6FF | 12mg | ||
POTASSIUM HYDROXIDE | INTRAVASCULAR | SOLUTION | 1310583 | WZH3C48M4T | NA | ||
POTASSIUM HYDROXIDE | INTRAVENOUS | INJECTION | 1310583 | WZH3C48M4T | ADJ PH | ||
POTASSIUM HYDROXIDE | ORAL | CAPSULE | 1310583 | WZH3C48M4T | 172mg | ||
POTASSIUM HYDROXIDE | ORAL | CAPSULE, DELAYED RELEASE | 1310583 | WZH3C48M4T | NA | ||
POTASSIUM HYDROXIDE | ORAL | CAPSULE, EXTENDED RELEASE | 1310583 | WZH3C48M4T | 0.07mg | ||
POTASSIUM HYDROXIDE | ORAL | CAPSULE, LIQUID FILLED | 1310583 | WZH3C48M4T | 154mg | ||
POTASSIUM HYDROXIDE | ORAL | PASTILLE | 1310583 | WZH3C48M4T | ADJ PH | ||
POTASSIUM HYDROXIDE | ORAL | SOLUTION | 1310583 | WZH3C48M4T | ADJ PH | ||
POTASSIUM HYDROXIDE | TOPICAL | AEROSOL, FOAM | 1310583 | WZH3C48M4T | ADJ PH | ||
POTASSIUM HYDROXIDE | TOPICAL | CREAM | 1310583 | WZH3C48M4T | 0.5%w/w | ||
POTASSIUM HYDROXIDE | TOPICAL | GEL | 1310583 | WZH3C48M4T | 3mg | ||
POTASSIUM HYDROXIDE | TOPICAL | SOLUTION | 1310583 | WZH3C48M4T | 14.02%w/w | ||
POTASSIUM HYDROXIDE | VAGINAL | CREAM | 1310583 | WZH3C48M4T | 0.5%w/w | ||
POTASSIUM METABISULFITE | AURICULAR (OTIC) | SOLUTION | 16731558 | 65OE787Q7W | 0.11%w/v | ||
POTASSIUM METABISULFITE | AURICULAR (OTIC) | SUSPENSION | 16731558 | 65OE787Q7W | NA | ||
POTASSIUM METABISULFITE | INTRAVENOUS | INJECTION | 16731558 | 65OE787Q7W | 0.6mg | ||
POTASSIUM METABISULFITE | INTRAVENOUS | INJECTION, SOLUTION | 16731558 | 65OE787Q7W | 0.05%w/v | ||
POTASSIUM METABISULFITE | ORAL | TABLET, COATED | 16731558 | 65OE787Q7W | 0.6mg | ||
POTASSIUM METABISULFITE | RECTAL | ENEMA | 16731558 | 65OE787Q7W | 282mg | ||
POTASSIUM METAPHOSPHATE | ORAL | SUSPENSION | 7790536 | 01DMT14Z63 | NA | ||
POTASSIUM SOAP | TOPICAL | SOLUTION | 8046740 | NA | 37.5%w/w | ||
POTASSIUM SORBATE | NASAL | SPRAY, METERED | 24634615 | 1VPU26JZZ4 | 1.2mg/1ml | ||
POTASSIUM SORBATE | OPHTHALMIC | EMULSION | 24634615 | 1VPU26JZZ4 | 0.47%w/v | ||
POTASSIUM SORBATE | OPHTHALMIC | SOLUTION/ DROPS | 24634615 | 1VPU26JZZ4 | 0.47%w/v | ||
POTASSIUM SORBATE | ORAL | CAPSULE | 24634615 | 1VPU26JZZ4 | NA | ||
POTASSIUM SORBATE | ORAL | CONCENTRATE | 24634615 | 1VPU26JZZ4 | 1mg | ||
POTASSIUM SORBATE | ORAL | GRANULE, FOR SUSPENSION | 24634615 | 1VPU26JZZ4 | 80mg | ||
POTASSIUM SORBATE | ORAL | PASTE | 24634615 | 1VPU26JZZ4 | 48mg | ||
POTASSIUM SORBATE | ORAL | POWDER, FOR SUSPENSION | 24634615 | 1VPU26JZZ4 | NA | ||
POTASSIUM SORBATE | ORAL | SOLUTION | 24634615 | 1VPU26JZZ4 | 1000mg/15ml | ||
POTASSIUM SORBATE | ORAL | SUSPENSION | 24634615 | 1VPU26JZZ4 | 400mg | ||
POTASSIUM SORBATE | ORAL | SYRUP | 24634615 | 1VPU26JZZ4 | 2mg/1ml | ||
POTASSIUM SORBATE | ORAL | TABLET | 24634615 | 1VPU26JZZ4 | 6mg | ||
POTASSIUM SORBATE | ORAL | TABLET, COATED | 24634615 | 1VPU26JZZ4 | NA | ||
POTASSIUM SORBATE | ORAL | TABLET, EXTENDED RELEASE | 24634615 | 1VPU26JZZ4 | 0.2mg | ||
POTASSIUM SORBATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 24634615 | 1VPU26JZZ4 | 0.2mg | ||
POTASSIUM SORBATE | RECTAL | SOLUTION | 24634615 | 1VPU26JZZ4 | 6.67%w/v | ||
POTASSIUM SORBATE | TOPICAL | AEROSOL, FOAM | 24634615 | 1VPU26JZZ4 | 8mg | Y | |
POTASSIUM SORBATE | TOPICAL | CREAM | 24634615 | 1VPU26JZZ4 | 0.25%w/w | ||
POTASSIUM SORBATE | TOPICAL | LOTION | 24634615 | 1VPU26JZZ4 | 0.2%w/w | ||
POTASSIUM SULFATE | INTRAMUSCULAR | INJECTION | 7778805 | 1K573LC5TV | 4mg | ||
POVIDONE | AURICULAR (OTIC) | SUSPENSION | 9003398 | FZ989GH94E | NA | ||
POVIDONE | INTRAMUSCULAR | INJECTION | 9003398 | FZ989GH94E | 0.2%w/v | ||
POVIDONE | OPHTHALMIC | SOLUTION | 9003398 | FZ989GH94E | 1.8%w/v | ||
POVIDONE | OPHTHALMIC | SUSPENSION | 9003398 | FZ989GH94E | 1.8%w/v | ||
POVIDONE | OPHTHALMIC | SUSPENSION/ DROPS | 9003398 | FZ989GH94E | 0.6%w/v | ||
POVIDONE | ORAL | CAPSULE | 9003398 | FZ989GH94E | 300mg | ||
POVIDONE | ORAL | CAPSULE, COATED PELLETS | 9003398 | FZ989GH94E | 10.03mg | ||
POVIDONE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9003398 | FZ989GH94E | NA | ||
POVIDONE | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | FZ989GH94E | NA | ||
POVIDONE | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | FZ989GH94E | 56mg | ||
POVIDONE | ORAL | DROPS | 9003398 | FZ989GH94E | NA | ||
POVIDONE | ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | 9003398 | FZ989GH94E | NA | ||
POVIDONE | ORAL | POWDER, FOR SOLUTION | 9003398 | FZ989GH94E | 4.5mg | ||
POVIDONE | ORAL | POWDER, FOR SUSPENSION | 9003398 | FZ989GH94E | 35mg/5ml | ||
POVIDONE | ORAL | SOLUTION | 9003398 | FZ989GH94E | 250mg/5ml | ||
POVIDONE | ORAL | SUSPENSION | 9003398 | FZ989GH94E | 20mg/5ml | ||
POVIDONE | ORAL | TABLET | 9003398 | FZ989GH94E | 216mg | ||
POVIDONE | ORAL | TABLET, CHEWABLE | 9003398 | FZ989GH94E | 18mg | ||
POVIDONE | ORAL | TABLET, COATED | 9003398 | FZ989GH94E | 49.2mg | ||
POVIDONE | ORAL | TABLET, DELAYED RELEASE | 9003398 | FZ989GH94E | 53mg | ||
POVIDONE | ORAL | TABLET, EXTENDED RELEASE | 9003398 | FZ989GH94E | 101mg | ||
POVIDONE | ORAL | TABLET, FILM COATED | 9003398 | FZ989GH94E | 240mg | ||
POVIDONE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9003398 | FZ989GH94E | 17mg | ||
POVIDONE | ORAL | TABLET, FOR SUSPENSION | 9003398 | FZ989GH94E | 2mg | ||
POVIDONE | ORAL | TABLET, ORALLY DISINTEGRATING | 9003398 | FZ989GH94E | 15.03mg | ||
POVIDONE | ORAL | TROCHE | 9003398 | FZ989GH94E | 30mg | ||
POVIDONE | SUBCUTANEOUS | IMPLANT | 9003398 | FZ989GH94E | 6mg | ||
POVIDONE | SUBLINGUAL | TABLET | 9003398 | FZ989GH94E | 6mg | ||
POVIDONE | TOPICAL | SYSTEM | 9003398 | FZ989GH94E | 41mg | ||
POVIDONE | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003398 | FZ989GH94E | NA | ||
POVIDONE K12 | INTRAVENOUS | INJECTION | 9003398 | 333AG72FWJ | 648mg | Y | |
POVIDONE K12 | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 9003398 | 333AG72FWJ | 0.2%w/v | ||
POVIDONE K12 | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9003398 | 333AG72FWJ | 600mg | ||
POVIDONE K12 | INTRAVENOUS | INJECTION, SUSPENSION | 9003398 | 333AG72FWJ | 0.08%w/v | ||
POVIDONE K12 | INTRAVENOUS | SOLUTION, CONCENTRATE | 9003398 | 333AG72FWJ | 1000mg | ||
POVIDONE K12 | ORAL | TABLET | 9003398 | 333AG72FWJ | 173mg | ||
POVIDONE K12 | SUBCUTANEOUS | INJECTION | 9003398 | 333AG72FWJ | 20mg | ||
POVIDONE K15 | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9003398 | E54VE15114 | 20mg | ||
POVIDONE K17 | ORAL | CAPSULE | 9003398 | C67P1734QJ | 130mg | ||
POVIDONE K17 | SUBCUTANEOUS | INJECTION, SUSPENSION | 9003398 | C67P1734QJ | 0.5%w/v | ||
POVIDONE K17 | SUBCUTANEOUS | SUSPENSION | 9003398 | C67P1734QJ | 0.5%w/v | ||
POVIDONE K25 | ORAL | CAPSULE | 9003398 | K0KQV10C35 | 200mg | ||
POVIDONE K25 | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | K0KQV10C35 | 10mg | ||
POVIDONE K25 | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | K0KQV10C35 | 67mg | ||
POVIDONE K25 | ORAL | GRANULE, FOR SUSPENSION | 9003398 | K0KQV10C35 | 0.27mg | ||
POVIDONE K25 | ORAL | POWDER, FOR SUSPENSION | 9003398 | K0KQV10C35 | 126mg | ||
POVIDONE K25 | ORAL | SOLUTION | 9003398 | K0KQV10C35 | 500mg/5ml | ||
POVIDONE K25 | ORAL | TABLET | 9003398 | K0KQV10C35 | 640mg | ||
POVIDONE K25 | ORAL | TABLET, CHEWABLE | 9003398 | K0KQV10C35 | 0.45mg | ||
POVIDONE K25 | ORAL | TABLET, COATED | 9003398 | K0KQV10C35 | 240mg | ||
POVIDONE K25 | ORAL | TABLET, DELAYED RELEASE | 9003398 | K0KQV10C35 | 49mg | ||
POVIDONE K25 | ORAL | TABLET, EXTENDED RELEASE | 9003398 | K0KQV10C35 | 200mg | ||
POVIDONE K25 | ORAL | TABLET, FILM COATED | 9003398 | K0KQV10C35 | 163mg | ||
POVIDONE K25 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9003398 | K0KQV10C35 | 11mg | ||
POVIDONE K25/30 | ORAL | TABLET | NA | 138mg | |||
POVIDONE K30 | BUCCAL | TABLET | 9003398 | U725QWY32X | 1mg | ||
POVIDONE K30 | INTRAMUSCULAR | INJECTION | 9003398 | U725QWY32X | 0.59%w/v | ||
POVIDONE K30 | OPHTHALMIC | SOLUTION | 9003398 | U725QWY32X | 42mg | ||
POVIDONE K30 | OPHTHALMIC | SOLUTION/ DROPS | 9003398 | U725QWY32X | 4mg | ||
POVIDONE K30 | OPHTHALMIC | SUSPENSION | 9003398 | U725QWY32X | 14mg | Y | |
POVIDONE K30 | ORAL | CAPSULE | 9003398 | U725QWY32X | 540mg | Y | |
POVIDONE K30 | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9003398 | U725QWY32X | 15mg | ||
POVIDONE K30 | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | U725QWY32X | 227mg | Y | |
POVIDONE K30 | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 9003398 | U725QWY32X | 178mg | ||
POVIDONE K30 | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | U725QWY32X | 120mg | ||
POVIDONE K30 | ORAL | CAPSULE, LIQUID FILLED | 9003398 | U725QWY32X | 101mg | ||
POVIDONE K30 | ORAL | GRANULE | 9003398 | U725QWY32X | 202mg | ||
POVIDONE K30 | ORAL | GRANULE, EFFERVESCENT | 9003398 | U725QWY32X | 40mg | ||
POVIDONE K30 | ORAL | GRANULE, FOR SUSPENSION | 9003398 | U725QWY32X | 120mg | ||
POVIDONE K30 | ORAL | LIQUID | 9003398 | U725QWY32X | 300mg | ||
POVIDONE K30 | ORAL | LOZENGE | 9003398 | U725QWY32X | 700mg | ||
POVIDONE K30 | ORAL | PELLET | 9003398 | U725QWY32X | 24mg | ||
POVIDONE K30 | ORAL | POWDER | 9003398 | U725QWY32X | 378mg | ||
POVIDONE K30 | ORAL | POWDER, FOR SOLUTION | 9003398 | U725QWY32X | 2832mg | ||
POVIDONE K30 | ORAL | POWDER, FOR SUSPENSION | 9003398 | U725QWY32X | 257mg | Y | |
POVIDONE K30 | ORAL | SOLUTION | 9003398 | U725QWY32X | 153mg | Y | |
POVIDONE K30 | ORAL | SUSPENSION | 9003398 | U725QWY32X | 148mg | ||
POVIDONE K30 | ORAL | SUSPENSION, EXTENDED RELEASE | 9003398 | U725QWY32X | 474mg | ||
POVIDONE K30 | ORAL | TABLET | 9003398 | U725QWY32X | 2828mg | ||
POVIDONE K30 | ORAL | TABLET, CHEWABLE | 9003398 | U725QWY32X | 245mg | ||
POVIDONE K30 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 9003398 | U725QWY32X | 12mg | ||
POVIDONE K30 | ORAL | TABLET, COATED | 9003398 | U725QWY32X | 160mg | ||
POVIDONE K30 | ORAL | TABLET, DELAYED RELEASE | 9003398 | U725QWY32X | 516mg | ||
POVIDONE K30 | ORAL | TABLET, DELAYED RELEASE PARTICLES | 9003398 | U725QWY32X | 70mg | ||
POVIDONE K30 | ORAL | TABLET, EXTENDED RELEASE | 9003398 | U725QWY32X | 230mg | ||
POVIDONE K30 | ORAL | TABLET, FILM COATED | 9003398 | U725QWY32X | 245mg | ||
POVIDONE K30 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9003398 | U725QWY32X | 45mg | ||
POVIDONE K30 | ORAL | TABLET, FOR SUSPENSION | 9003398 | U725QWY32X | 462mg | ||
POVIDONE K30 | ORAL | TABLET, ORALLY DISINTEGRATING | 9003398 | U725QWY32X | 71mg | ||
POVIDONE K30 | ORAL | TROCHE | 9003398 | U725QWY32X | 100mg | ||
POVIDONE K30 | SUBLINGUAL | FILM | 9003398 | U725QWY32X | 7mg | ||
POVIDONE K30 | SUBLINGUAL | TABLET | 9003398 | U725QWY32X | 30mg | ||
POVIDONE K30 | TOPICAL | AEROSOL, FOAM | 9003398 | U725QWY32X | 1.9%w/w | ||
POVIDONE K30 | TOPICAL | SOLUTION | 9003398 | U725QWY32X | 4%w/v | ||
POVIDONE K30 | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003398 | U725QWY32X | 16mg | ||
POVIDONE K30 | TRANSDERMAL | SYSTEM | 9003398 | U725QWY32X | 15mg | ||
POVIDONE K30 | VAGINAL | INSERT | 9003398 | U725QWY32X | 147mg | ||
POVIDONE K90 | AURICULAR (OTIC) | SOLUTION/ DROPS | 9003398 | RDH86HJV5Z | 1mg | ||
POVIDONE K90 | OPHTHALMIC | SOLUTION | 9003398 | RDH86HJV5Z | 0.3%w/v | ||
POVIDONE K90 | OPHTHALMIC | SOLUTION/ DROPS | 9003398 | RDH86HJV5Z | 1.2%w/w | ||
POVIDONE K90 | OPHTHALMIC | SUSPENSION/ DROPS | 9003398 | RDH86HJV5Z | 1.5%w/v | ||
POVIDONE K90 | ORAL | CAPSULE | 9003398 | RDH86HJV5Z | 270mg | ||
POVIDONE K90 | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | RDH86HJV5Z | 137mg | ||
POVIDONE K90 | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | RDH86HJV5Z | 118mg | ||
POVIDONE K90 | ORAL | GRANULE, FOR SUSPENSION | 9003398 | RDH86HJV5Z | 140mg | ||
POVIDONE K90 | ORAL | SUSPENSION | 9003398 | RDH86HJV5Z | 2mg | ||
POVIDONE K90 | ORAL | TABLET | 9003398 | RDH86HJV5Z | 966mg | ||
POVIDONE K90 | ORAL | TABLET, COATED | 9003398 | RDH86HJV5Z | 9.77mg | ||
POVIDONE K90 | ORAL | TABLET, DELAYED RELEASE | 9003398 | RDH86HJV5Z | 192mg | ||
POVIDONE K90 | ORAL | TABLET, EXTENDED RELEASE | 9003398 | RDH86HJV5Z | 498mg | ||
POVIDONE K90 | ORAL | TABLET, FILM COATED | 9003398 | RDH86HJV5Z | 128mg | ||
POVIDONE K90 | TOPICAL | SOLUTION | 9003398 | RDH86HJV5Z | 120mg | ||
POVIDONE K90 | TOPICAL | SYSTEM | 9003398 | RDH86HJV5Z | 280mg | ||
POVIDONE K90 | TRANSDERMAL | SOLUTION | 9003398 | RDH86HJV5Z | 100mg | ||
POVIDONE K90 | TRANSDERMAL | SYSTEM | 9003398 | RDH86HJV5Z | 20mg | ||
POVIDONE/EICOSENE COPOLYMER | TOPICAL | CREAM | 28211189 | NA | 1%w/w | ||
POVIDONE/EICOSENE COPOLYMER | TOPICAL | LOTION | 28211189 | NA | 1%w/w | ||
POWDERED CELLULOSE | BUCCAL | TABLET | 9004346 | SMD1X3XO9M | 4.5mg | ||
POWDERED CELLULOSE | DENTAL | PASTE, DENTIFRICE | 9004346 | SMD1X3XO9M | NA | ||
POWDERED CELLULOSE | EXTRACORPOREAL | DISC | 9004346 | SMD1X3XO9M | NA | ||
POWDERED CELLULOSE | ORAL | CAPSULE | 9004346 | SMD1X3XO9M | 2430mg | Y | |
POWDERED CELLULOSE | ORAL | DROPS | 9004346 | SMD1X3XO9M | NA | ||
POWDERED CELLULOSE | ORAL | LIQUID | 9004346 | SMD1X3XO9M | NA | ||
POWDERED CELLULOSE | ORAL | POWDER, FOR SUSPENSION | 9004346 | SMD1X3XO9M | 1600mg | ||
POWDERED CELLULOSE | ORAL | SUSPENSION | 9004346 | SMD1X3XO9M | 400mg | ||
POWDERED CELLULOSE | ORAL | TABLET | 9004346 | SMD1X3XO9M | 1582mg | ||
POWDERED CELLULOSE | ORAL | TABLET, CHEWABLE | 9004346 | SMD1X3XO9M | NA | ||
POWDERED CELLULOSE | ORAL | TABLET, COATED | 9004346 | SMD1X3XO9M | 40.2mg | ||
POWDERED CELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004346 | SMD1X3XO9M | 16mg | ||
POWDERED CELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004346 | SMD1X3XO9M | 110.6mg | ||
POWDERED CELLULOSE | ORAL | TABLET, FILM COATED | 9004346 | SMD1X3XO9M | 392mg | ||
POWDERED CELLULOSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004346 | SMD1X3XO9M | 42.25mg | ||
POWDERED CELLULOSE | SUBLINGUAL | TABLET | 9004346 | SMD1X3XO9M | 4.5mg | ||
POWDERED CELLULOSE | TOPICAL | DISC | 9004346 | SMD1X3XO9M | NA | ||
PPG-12/SMDI COPOLYMER | TOPICAL | CREAM | 9042824 | 1BK9DDD24E | 1%w/w | ||
PPG-12/SMDI COPOLYMER | TOPICAL | LOTION | 9042824 | 1BK9DDD24E | 3%w/w | ||
PPG-20 METHYL GLUCOSE ETHER DISTEARATE | TOPICAL | GEL | 93821740 | 0057334FAB | 48mg | ||
PPG-26 OLEATE | TOPICAL | CREAM | 31394715 | G6ZWA1Q43P | 4%w/w | ||
PROLINE | INTRAVENOUS | INJECTION | 147853 | 9DLQ4CIU6V | 0.8%w/v | ||
PROLINE | INTRAVENOUS | INJECTION, SOLUTION | 147853 | 9DLQ4CIU6V | 0.34%w/v | ||
PROMULGEN D | TOPICAL | LOTION | NA | 3.5%w/w | |||
PROMULGEN G | TOPICAL | LOTION | 9009614 | NA | 2.16%w/w | ||
PROMULGEN G | TOPICAL | SHAMPOO | 9009614 | NA | 4%w/w | ||
PROPANE | RECTAL | AEROSOL, FOAM | 74986 | T75W9911L6 | 9mg | ||
PROPANE | TOPICAL | AEROSOL, FOAM | 74986 | T75W9911L6 | 55%w/w | ||
PROPIONIC ACID | TOPICAL | OINTMENT | 79094 | JHU490RVYR | 2.7%w/w | ||
PROPYL ALCOHOL | TOPICAL | OINTMENT | 71238 | 96F264O9SV | 10%w/w | ||
PROPYL ALCOHOL | TOPICAL | POWDER | 71238 | 96F264O9SV | 0.4mg/mg | ||
PROPYL ALCOHOL | TOPICAL | SOLUTION | 71238 | 96F264O9SV | NA | ||
PROPYL GALLATE | ORAL | CAPSULE | 121799 | 8D4SNN7V92 | 4mg | ||
PROPYL GALLATE | ORAL | CONCENTRATE | 121799 | 8D4SNN7V92 | 0.2mg/1ml | ||
PROPYL GALLATE | ORAL | SUSPENSION, EXTENDED RELEASE | 121799 | 8D4SNN7V92 | 4mg | ||
PROPYL GALLATE | ORAL | TABLET | 121799 | 8D4SNN7V92 | 7mg | ||
PROPYL GALLATE | ORAL | TABLET, EXTENDED RELEASE | 121799 | 8D4SNN7V92 | 0.07mg | ||
PROPYL GALLATE | ORAL | TABLET, FILM COATED | 121799 | 8D4SNN7V92 | 0.04mg | ||
PROPYL GALLATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 121799 | 8D4SNN7V92 | 0.04mg | ||
PROPYL GALLATE | TOPICAL | CREAM | 121799 | 8D4SNN7V92 | NA | ||
PROPYL GALLATE | TOPICAL | GEL | 121799 | 8D4SNN7V92 | 0.05%w/w | ||
PROPYL GALLATE | TOPICAL | OINTMENT | 121799 | 8D4SNN7V92 | NA | ||
PROPYLENE CARBONATE | TOPICAL | OINTMENT | 108327 | 8D08K3S51E | 3000mg | ||
PROPYLENE GLYCOL | AURICULAR (OTIC) | SOLUTION | 57556 | 6DC9Q167V3 | 56.55%w/v | ||
PROPYLENE GLYCOL | AURICULAR (OTIC) | SOLUTION/ DROPS | 57556 | 6DC9Q167V3 | ADJ PH | ||
PROPYLENE GLYCOL | AURICULAR (OTIC) | SUSPENSION | 57556 | 6DC9Q167V3 | 10%w/v | ||
PROPYLENE GLYCOL | BUCCAL | FILM | 57556 | 6DC9Q167V3 | 1.48mg | ||
PROPYLENE GLYCOL | BUCCAL | FILM, SOLUBLE | 57556 | 6DC9Q167V3 | 5mg | ||
PROPYLENE GLYCOL | DENTAL | OINTMENT | 57556 | 6DC9Q167V3 | NA | ||
PROPYLENE GLYCOL | DENTAL | PASTE | 57556 | 6DC9Q167V3 | 0.5%w/w | ||
PROPYLENE GLYCOL | DENTAL | SOLUTION | 57556 | 6DC9Q167V3 | 2%w/w | ||
PROPYLENE GLYCOL | INTRAMUSCULAR | INJECTION | 57556 | 6DC9Q167V3 | 7459mg | ||
PROPYLENE GLYCOL | INTRAMUSCULAR | INJECTION, SOLUTION | 57556 | 6DC9Q167V3 | 4000mg | ||
PROPYLENE GLYCOL | INTRAVENOUS | INJECTION | 57556 | 6DC9Q167V3 | 16624mg | ||
PROPYLENE GLYCOL | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 57556 | 6DC9Q167V3 | 63.4%w/v | ||
PROPYLENE GLYCOL | INTRAVENOUS | INJECTION, SOLUTION | 57556 | 6DC9Q167V3 | 4000mg | ||
PROPYLENE GLYCOL | INTRAVENOUS | SOLUTION | 57556 | 6DC9Q167V3 | 5%w/v | ||
PROPYLENE GLYCOL | INTRAVENOUS | SOLUTION, CONCENTRATE | 57556 | 6DC9Q167V3 | 50.33%w/v | ||
PROPYLENE GLYCOL | NASAL | SOLUTION | 57556 | 6DC9Q167V3 | 12000mg/100ml | ||
PROPYLENE GLYCOL | NASAL | SPRAY | 57556 | 6DC9Q167V3 | 49.7mg/1ml | ||
PROPYLENE GLYCOL | NASAL | SPRAY, METERED | 57556 | 6DC9Q167V3 | 50mg/1ml | ||
PROPYLENE GLYCOL | OPHTHALMIC | EMULSION | 57556 | 6DC9Q167V3 | 1.5%w/v | ||
PROPYLENE GLYCOL | OPHTHALMIC | GEL | 57556 | 6DC9Q167V3 | 0.44%w/w | ||
PROPYLENE GLYCOL | OPHTHALMIC | SOLUTION | 57556 | 6DC9Q167V3 | 1%w/v | ||
PROPYLENE GLYCOL | OPHTHALMIC | SOLUTION/ DROPS | 57556 | 6DC9Q167V3 | 0.75%w/v | ||
PROPYLENE GLYCOL | OPHTHALMIC | SUSPENSION | 57556 | 6DC9Q167V3 | 0.6%w/v | ||
PROPYLENE GLYCOL | OPHTHALMIC | SUSPENSION/ DROPS | 57556 | 6DC9Q167V3 | 0.75%w/v | ||
PROPYLENE GLYCOL | ORAL | CAPSULE | 57556 | 6DC9Q167V3 | 1072mg | ||
PROPYLENE GLYCOL | ORAL | CAPSULE, COATED | 57556 | 6DC9Q167V3 | 25mg | ||
PROPYLENE GLYCOL | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | NA | ||
PROPYLENE GLYCOL | ORAL | CAPSULE, DELAYED RELEASE | 57556 | 6DC9Q167V3 | 1.7mg | ||
PROPYLENE GLYCOL | ORAL | CAPSULE, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | 14.6mg | ||
PROPYLENE GLYCOL | ORAL | CAPSULE, LIQUID FILLED | 57556 | 6DC9Q167V3 | 42mg | ||
PROPYLENE GLYCOL | ORAL | CONCENTRATE | 57556 | 6DC9Q167V3 | 7000mg | ||
PROPYLENE GLYCOL | ORAL | DROPS | 57556 | 6DC9Q167V3 | 200mg/1ml | ||
PROPYLENE GLYCOL | ORAL | ELIXIR | 57556 | 6DC9Q167V3 | 9306mg | ||
PROPYLENE GLYCOL | ORAL | LIQUID | 57556 | 6DC9Q167V3 | 29008mg | ||
PROPYLENE GLYCOL | ORAL | SOLUTION | 57556 | 6DC9Q167V3 | 22602mg | ||
PROPYLENE GLYCOL | ORAL | SOLUTION, CONCENTRATE | 57556 | 6DC9Q167V3 | 2590mg | ||
PROPYLENE GLYCOL | ORAL | SUSPENSION | 57556 | 6DC9Q167V3 | 27120mg | ||
PROPYLENE GLYCOL | ORAL | SUSPENSION, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | 1000mg | ||
PROPYLENE GLYCOL | ORAL | SYRUP | 57556 | 6DC9Q167V3 | 5700mg | ||
PROPYLENE GLYCOL | ORAL | TABLET | 57556 | 6DC9Q167V3 | 64mg | ||
PROPYLENE GLYCOL | ORAL | TABLET, COATED | 57556 | 6DC9Q167V3 | 16mg | ||
PROPYLENE GLYCOL | ORAL | TABLET, DELAYED RELEASE | 57556 | 6DC9Q167V3 | 36mg | ||
PROPYLENE GLYCOL | ORAL | TABLET, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | 9mg | ||
PROPYLENE GLYCOL | ORAL | TABLET, FILM COATED | 57556 | 6DC9Q167V3 | 96mg | ||
PROPYLENE GLYCOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | 19mg | ||
PROPYLENE GLYCOL | RECTAL | AEROSOL, FOAM | 57556 | 6DC9Q167V3 | 1214mg | ||
PROPYLENE GLYCOL | RECTAL | AEROSOL, METERED | 57556 | 6DC9Q167V3 | NA | ||
PROPYLENE GLYCOL | RECTAL | GEL | 57556 | 6DC9Q167V3 | 3315mg | ||
PROPYLENE GLYCOL | RECTAL | OINTMENT | 57556 | 6DC9Q167V3 | 3.6%w/w | ||
PROPYLENE GLYCOL | RECTAL | SUSPENSION | 57556 | 6DC9Q167V3 | 90400mg | ||
PROPYLENE GLYCOL | RESPIRATORY (INHALATION) | LIQUID | 57556 | 6DC9Q167V3 | 10%w/w | ||
PROPYLENE GLYCOL | RESPIRATORY (INHALATION) | SOLUTION | 57556 | 6DC9Q167V3 | 25%w/w | ||
PROPYLENE GLYCOL | SUBCUTANEOUS | INJECTION | 57556 | 6DC9Q167V3 | 1.4%w/v | ||
PROPYLENE GLYCOL | SUBCUTANEOUS | INJECTION, SOLUTION | 57556 | 6DC9Q167V3 | 1.4%w/v | ||
PROPYLENE GLYCOL | SUBLINGUAL | SPRAY | 57556 | 6DC9Q167V3 | 36mg | ||
PROPYLENE GLYCOL | TOPICAL | AEROSOL | 57556 | 6DC9Q167V3 | 19.2%w/w | ||
PROPYLENE GLYCOL | TOPICAL | AEROSOL, FOAM | 57556 | 6DC9Q167V3 | 1800mg | ||
PROPYLENE GLYCOL | TOPICAL | CLOTH | 57556 | 6DC9Q167V3 | 0.03mg/mg | ||
PROPYLENE GLYCOL | TOPICAL | CREAM | 57556 | 6DC9Q167V3 | 6113mg | ||
PROPYLENE GLYCOL | TOPICAL | CREAM, AUGMENTED | 57556 | 6DC9Q167V3 | 30%w/w | ||
PROPYLENE GLYCOL | TOPICAL | EMULSION | 57556 | 6DC9Q167V3 | 8%w/w | ||
PROPYLENE GLYCOL | TOPICAL | GEL | 57556 | 6DC9Q167V3 | 4522mg | ||
PROPYLENE GLYCOL | TOPICAL | GEL, METERED | 57556 | 6DC9Q167V3 | 1225mg | ||
PROPYLENE GLYCOL | TOPICAL | JELLY | 57556 | 6DC9Q167V3 | 20%w/w | ||
PROPYLENE GLYCOL | TOPICAL | LOTION | 57556 | 6DC9Q167V3 | 3392mg | ||
PROPYLENE GLYCOL | TOPICAL | LOTION, AUGMENTED | 57556 | 6DC9Q167V3 | 2055mg | ||
PROPYLENE GLYCOL | TOPICAL | OINTMENT | 57556 | 6DC9Q167V3 | 1312mg | ||
PROPYLENE GLYCOL | TOPICAL | OINTMENT, AUGMENTED | 57556 | 6DC9Q167V3 | 714mg | Y | |
PROPYLENE GLYCOL | TOPICAL | SHAMPOO | 57556 | 6DC9Q167V3 | 8%w/w | ||
PROPYLENE GLYCOL | TOPICAL | SHAMPOO, SUSPENSION | 57556 | 6DC9Q167V3 | 2%w/w | ||
PROPYLENE GLYCOL | TOPICAL | SOLUTION | 57556 | 6DC9Q167V3 | 1936mg | ||
PROPYLENE GLYCOL | TOPICAL | SPONGE | 57556 | 6DC9Q167V3 | 40%w/w | ||
PROPYLENE GLYCOL | TOPICAL | SUSPENSION | 57556 | 6DC9Q167V3 | 5.28%w/v | ||
PROPYLENE GLYCOL | TOPICAL | SUSPENSION/ DROPS | 57556 | 6DC9Q167V3 | 0.75%w/v | ||
PROPYLENE GLYCOL | TOPICAL | SWAB | 57556 | 6DC9Q167V3 | 34.6%w/w | ||
PROPYLENE GLYCOL | TOPICAL | SYSTEM | 57556 | 6DC9Q167V3 | 4200mg | ||
PROPYLENE GLYCOL | TRANSDERMAL | FILM, EXTENDED RELEASE | 57556 | 6DC9Q167V3 | 58.13mg | ||
PROPYLENE GLYCOL | TRANSDERMAL | GEL | 57556 | 6DC9Q167V3 | 156mg | ||
PROPYLENE GLYCOL | VAGINAL | AEROSOL, FOAM | 57556 | 6DC9Q167V3 | 6.4%w/w | ||
PROPYLENE GLYCOL | VAGINAL | CREAM | 57556 | 6DC9Q167V3 | 400mg | ||
PROPYLENE GLYCOL | VAGINAL | GEL | 57556 | 6DC9Q167V3 | 750mg | ||
PROPYLENE GLYCOL | VAGINAL | SUPPOSITORY | 57556 | 6DC9Q167V3 | 252mg | ||
PROPYLENE GLYCOL | VAGINAL | TAMPON | 57556 | 6DC9Q167V3 | 62.1mg | ||
PROPYLENE GLYCOL - LECITHIN | BUCCAL | SYSTEM | NA | 49.4mg | |||
PROPYLENE GLYCOL - LECITHIN | ORAL | SOLUTION | NA | 39744mg | |||
PROPYLENE GLYCOL ALGINATE | ORAL | EMULSION | 9005372 | 26CD3J2R0C | 0.15mg/1ml | ||
PROPYLENE GLYCOL ALGINATE | ORAL | GRANULE, FOR SUSPENSION | 9005372 | 26CD3J2R0C | NA | ||
PROPYLENE GLYCOL ALGINATE | ORAL | POWDER | 9005372 | 26CD3J2R0C | 718mg | ||
PROPYLENE GLYCOL ALGINATE | ORAL | POWDER, FOR SUSPENSION | 9005372 | 26CD3J2R0C | 2716mg | ||
PROPYLENE GLYCOL ALGINATE | ORAL | SUSPENSION | 9005372 | 26CD3J2R0C | 0.15mg/1ml | ||
PROPYLENE GLYCOL ALGINATE | ORAL | TABLET | 9005372 | 26CD3J2R0C | 80mg | ||
PROPYLENE GLYCOL DIACETATE | AURICULAR (OTIC) | SOLUTION | 623847 | 5Z492UNF9O | 3%w/v | ||
PROPYLENE GLYCOL DIACETATE | OPHTHALMIC | SOLUTION/ DROPS | 623847 | 5Z492UNF9O | 3%w/w | ||
PROPYLENE GLYCOL DIACETATE | TOPICAL | CREAM | 623847 | 5Z492UNF9O | 10%w/w | ||
PROPYLENE GLYCOL DICAPRYLATE | TOPICAL | CREAM | 7384987 | 581437HWX2 | 10%w/w | ||
PROPYLENE GLYCOL MONOCAPRYLATE | ORAL | TABLET, FILM COATED | 31565125 | RT9P9S09QI | 24mg | ||
PROPYLENE GLYCOL MONOLAURATE | ORAL | CAPSULE | 27194747 | 668Z5835Z3 | 2115mg | ||
PROPYLENE GLYCOL MONOLAURATE | ORAL | TABLET | 27194747 | 668Z5835Z3 | 20mg | ||
PROPYLENE GLYCOL MONOLAURATE | ORAL | TABLET, FILM COATED | 27194747 | 668Z5835Z3 | 20mg | ||
PROPYLENE GLYCOL MONOLAURATE | TOPICAL | GEL | 27194747 | 668Z5835Z3 | 3%w/w | ||
PROPYLENE GLYCOL MONOLAURATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 27194747 | 668Z5835Z3 | NA | ||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | TOPICAL | CREAM | F76354LMGR | 9.3%w/w | |||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | TOPICAL | LOTION | F76354LMGR | 4.69%w/w | |||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | TOPICAL | OINTMENT | F76354LMGR | 8%w/w | |||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | TOPICAL | OINTMENT, AUGMENTED | F76354LMGR | 143mg | Y | ||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | VAGINAL | CREAM | F76354LMGR | 7%w/w | |||
PROPYLENE GLYCOL MONOPALMITOSTEARATE | VAGINAL | SUPPOSITORY | F76354LMGR | 135mg | |||
PROPYLENE GLYCOL MONOSTEARATE | TOPICAL | CREAM | 1323393 | MZM1I680W0 | 9.3%w/w | ||
PROPYLENE GLYCOL MONOSTEARATE | TOPICAL | LOTION | 1323393 | MZM1I680W0 | 3%w/w | ||
PROPYLENE GLYCOL MONOSTEARATE | TOPICAL | OINTMENT | 1323393 | MZM1I680W0 | 8%w/w | ||
PROPYLENE GLYCOL MONOSTEARATE | VAGINAL | CREAM | 1323393 | MZM1I680W0 | 140mg | Y | |
PROPYLPARABEN | AURICULAR (OTIC) | DROPS | 94133 | Z8IX2SC1OH | NA | ||
PROPYLPARABEN | AURICULAR (OTIC) | SUSPENSION | 94133 | Z8IX2SC1OH | NA | ||
PROPYLPARABEN | BUCCAL | FILM | 94133 | Z8IX2SC1OH | 0.22mg | ||
PROPYLPARABEN | BUCCAL | FILM, SOLUBLE | 94133 | Z8IX2SC1OH | 1mg | ||
PROPYLPARABEN | DENTAL | PASTE, DENTIFRICE | 94133 | Z8IX2SC1OH | NA | ||
PROPYLPARABEN | INFILTRATION | INJECTION | 94133 | Z8IX2SC1OH | 0.35mg | ||
PROPYLPARABEN | INTRA-ARTICULAR | INJECTION | 94133 | Z8IX2SC1OH | 0.03%w/v | ||
PROPYLPARABEN | INTRALESIONAL | INJECTION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | INTRAMUSCULAR | INJECTION | 94133 | Z8IX2SC1OH | 6mg | ||
PROPYLPARABEN | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 94133 | Z8IX2SC1OH | 0.4mg | ||
PROPYLPARABEN | INTRAMUSCULAR | INJECTION, SOLUTION | 94133 | Z8IX2SC1OH | 5mg | ||
PROPYLPARABEN | INTRAMUSCULAR | INJECTION, SUSPENSION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | INTRAMUSCULAR | SOLUTION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | INTRAVENOUS | INJECTION | 94133 | Z8IX2SC1OH | 6mg | ||
PROPYLPARABEN | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 94133 | Z8IX2SC1OH | 0.8mg | ||
PROPYLPARABEN | INTRAVENOUS | INJECTION, SOLUTION | 94133 | Z8IX2SC1OH | 5mg | ||
PROPYLPARABEN | INTRAVENOUS | SOLUTION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | NASAL | DROPS | 94133 | Z8IX2SC1OH | 14mg | ||
PROPYLPARABEN | NASAL | JELLY | 94133 | Z8IX2SC1OH | 140mg | ||
PROPYLPARABEN | NASAL | SOLUTION | 94133 | Z8IX2SC1OH | 140mg | ||
PROPYLPARABEN | NASAL | SPRAY | 94133 | Z8IX2SC1OH | 0.2mg | ||
PROPYLPARABEN | OPHTHALMIC | DROPS | 94133 | Z8IX2SC1OH | 0.01%w/w | ||
PROPYLPARABEN | OPHTHALMIC | OINTMENT | 94133 | Z8IX2SC1OH | 0.01%w/w | ||
PROPYLPARABEN | OPHTHALMIC | SOLUTION | 94133 | Z8IX2SC1OH | 0.02%w/w | ||
PROPYLPARABEN | OPHTHALMIC | SOLUTION/ DROPS | 94133 | Z8IX2SC1OH | 0.01%w/v | ||
PROPYLPARABEN | OPHTHALMIC | SUSPENSION/ DROPS | 94133 | Z8IX2SC1OH | 0.01%w/w | ||
PROPYLPARABEN | ORAL | CAPSULE | 94133 | Z8IX2SC1OH | 1mg | ||
PROPYLPARABEN | ORAL | CAPSULE, EXTENDED RELEASE | 94133 | Z8IX2SC1OH | 0.22mg | ||
PROPYLPARABEN | ORAL | CONCENTRATE | 94133 | Z8IX2SC1OH | 2.5mg/5ml | ||
PROPYLPARABEN | ORAL | ELIXIR | 94133 | Z8IX2SC1OH | 200mg | ||
PROPYLPARABEN | ORAL | LIQUID | 94133 | Z8IX2SC1OH | 2mg | ||
PROPYLPARABEN | ORAL | POWDER | 94133 | Z8IX2SC1OH | NA | ||
PROPYLPARABEN | ORAL | POWDER, FOR SOLUTION | 94133 | Z8IX2SC1OH | 3mg | ||
PROPYLPARABEN | ORAL | POWDER, FOR SUSPENSION | 94133 | Z8IX2SC1OH | 4mg/5ml | ||
PROPYLPARABEN | ORAL | SOLUTION | 94133 | Z8IX2SC1OH | 100mg | ||
PROPYLPARABEN | ORAL | SOLUTION, CONCENTRATE | 94133 | Z8IX2SC1OH | 0.2mg/1ml | ||
PROPYLPARABEN | ORAL | SUSPENSION | 94133 | Z8IX2SC1OH | 200mg/5ml | ||
PROPYLPARABEN | ORAL | SUSPENSION, EXTENDED RELEASE | 94133 | Z8IX2SC1OH | 4mg | ||
PROPYLPARABEN | ORAL | SYRUP | 94133 | Z8IX2SC1OH | 200mg/5ml | ||
PROPYLPARABEN | ORAL | TABLET | 94133 | Z8IX2SC1OH | 0.2mg | ||
PROPYLPARABEN | ORAL | TABLET, CHEWABLE | 94133 | Z8IX2SC1OH | 0.14mg | ||
PROPYLPARABEN | ORAL | TABLET, COATED | 94133 | Z8IX2SC1OH | 0.8mg | ||
PROPYLPARABEN | ORAL | TABLET, EXTENDED RELEASE | 94133 | Z8IX2SC1OH | 0.12mg | ||
PROPYLPARABEN | ORAL | TABLET, FILM COATED | 94133 | Z8IX2SC1OH | 0.04mg | ||
PROPYLPARABEN | PARENTERAL | INJECTION | 94133 | Z8IX2SC1OH | 2mg | ||
PROPYLPARABEN | RECTAL | ENEMA | 94133 | Z8IX2SC1OH | 0.02%w/w | ||
PROPYLPARABEN | RECTAL | SOLUTION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | RECTAL | SUSPENSION | 94133 | Z8IX2SC1OH | 271mg | ||
PROPYLPARABEN | RESPIRATORY (INHALATION) | SOLUTION | 94133 | Z8IX2SC1OH | 0.01%w/w | ||
PROPYLPARABEN | SOFT TISSUE | INJECTION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | SUBCUTANEOUS | INJECTION | 94133 | Z8IX2SC1OH | 2mg | ||
PROPYLPARABEN | SUBCUTANEOUS | INJECTION, SUSPENSION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | SUBCUTANEOUS | SUSPENSION | 94133 | Z8IX2SC1OH | 0.02%w/v | ||
PROPYLPARABEN | TOPICAL | AEROSOL, FOAM | 94133 | Z8IX2SC1OH | 0.04%w/w | ||
PROPYLPARABEN | TOPICAL | CREAM | 94133 | Z8IX2SC1OH | 6mg | ||
PROPYLPARABEN | TOPICAL | CREAM, AUGMENTED | 94133 | Z8IX2SC1OH | 2mg | ||
PROPYLPARABEN | TOPICAL | EMULSION | 94133 | Z8IX2SC1OH | 0.06%w/w | ||
PROPYLPARABEN | TOPICAL | GEL | 94133 | Z8IX2SC1OH | 1mg | ||
PROPYLPARABEN | TOPICAL | JELLY | 94133 | Z8IX2SC1OH | 0.03%w/v | ||
PROPYLPARABEN | TOPICAL | LIQUID | 94133 | Z8IX2SC1OH | 0.1%w/w | ||
PROPYLPARABEN | TOPICAL | LOTION | 94133 | Z8IX2SC1OH | 140mg | ||
PROPYLPARABEN | TOPICAL | OINTMENT | 94133 | Z8IX2SC1OH | 0.2%w/w | ||
PROPYLPARABEN | TOPICAL | SHAMPOO | 94133 | Z8IX2SC1OH | 0.03%w/w | ||
PROPYLPARABEN | TOPICAL | SOLUTION | 94133 | Z8IX2SC1OH | 24mg | ||
PROPYLPARABEN | TOPICAL | SPRAY | 94133 | Z8IX2SC1OH | 0.8%w/w | ||
PROPYLPARABEN | TOPICAL | SYSTEM | 94133 | Z8IX2SC1OH | 21mg | ||
PROPYLPARABEN | URETHRAL | JELLY | 94133 | Z8IX2SC1OH | 0.03%w/v | ||
PROPYLPARABEN | VAGINAL | CREAM | 94133 | Z8IX2SC1OH | 0.1%w/w | ||
PROPYLPARABEN | VAGINAL | GEL | 94133 | Z8IX2SC1OH | 2mg | ||
PROPYLPARABEN | VAGINAL | SUPPOSITORY | 94133 | Z8IX2SC1OH | NA | ||
PROPYLPARABEN SODIUM | ORAL | CAPSULE | 35285699 | 625NNB0G9N | 1mg | ||
PROPYLPARABEN SODIUM | ORAL | POWDER, FOR SUSPENSION | 35285699 | 625NNB0G9N | 16mg | ||
PROPYLPARABEN SODIUM | ORAL | SOLUTION | 35285699 | 625NNB0G9N | 30mg | ||
PROPYLPARABEN SODIUM | ORAL | SUSPENSION | 35285699 | 625NNB0G9N | 4mg | ||
PROPYLPARABEN SODIUM | ORAL | TABLET | 35285699 | 625NNB0G9N | 0.06mg | ||
PROPYLPARABEN SODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 35285699 | 625NNB0G9N | 0.1mg | ||
PROSOLV ODT | ORAL | TABLET, EXTENDED RELEASE | 2379319829 | 7ASB3EQN9N | 791mg | ||
PROSOLV ODT | ORAL | TABLET, ORALLY DISINTEGRATING | 2379319829 | 7ASB3EQN9N | 858mg | Y | |
PROSWEET | ORAL | SOLUTION | NA | 52.75mg/5ml | |||
PROSWEET | ORAL | SUSPENSION | NA | 50mg/5ml | |||
PROSWEET | ORAL | TABLET, CHEWABLE | NA | 60mg | |||
PROSWEET K | ORAL | SYRUP | NA | 4mg/1ml | |||
PROTAMINE SULFATE | INTRADERMAL | INJECTION | 9009658 | 0DE9724IHC | 0.13%w/v | ||
PROTAMINE SULFATE | INTRAMUSCULAR | INJECTION | 9009658 | 0DE9724IHC | NA | ||
PROTAMINE SULFATE | SUBCUTANEOUS | INJECTION | 9009658 | 0DE9724IHC | 0.04%w/v | ||
PROTAMINE SULFATE | SUBCUTANEOUS | INJECTION, SUSPENSION | 9009658 | 0DE9724IHC | 0.01%w/v | ||
PROTEIN HYDROLYSATE | ORAL | TABLET, FILM COATED | 9015547 | NA | 15mg | ||
PROTEIN HYDROLYSATE | TOPICAL | LOTION | 9015547 | NA | 0.39%w/w | ||
PULLULAN | ORAL | TABLET | 9057027 | 8ZQ0AYU1TT | 10mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024